JPH02264944A - X-ray image forming method - Google Patents
X-ray image forming methodInfo
- Publication number
- JPH02264944A JPH02264944A JP8736689A JP8736689A JPH02264944A JP H02264944 A JPH02264944 A JP H02264944A JP 8736689 A JP8736689 A JP 8736689A JP 8736689 A JP8736689 A JP 8736689A JP H02264944 A JPH02264944 A JP H02264944A
- Authority
- JP
- Japan
- Prior art keywords
- group
- development
- silver halide
- layer
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 65
- -1 silver halide Chemical class 0.000 claims abstract description 79
- 239000000839 emulsion Substances 0.000 claims abstract description 50
- 239000000463 material Substances 0.000 claims abstract description 50
- 238000011161 development Methods 0.000 claims abstract description 45
- 229910052709 silver Inorganic materials 0.000 claims abstract description 43
- 239000004332 silver Substances 0.000 claims abstract description 42
- 230000035945 sensitivity Effects 0.000 abstract description 15
- 230000002250 progressing effect Effects 0.000 abstract 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000000975 dye Substances 0.000 description 76
- 239000010410 layer Substances 0.000 description 75
- 230000018109 developmental process Effects 0.000 description 39
- 238000012545 processing Methods 0.000 description 35
- 108010010803 Gelatin Proteins 0.000 description 27
- 239000008273 gelatin Substances 0.000 description 27
- 229920000159 gelatin Polymers 0.000 description 27
- 235000019322 gelatine Nutrition 0.000 description 27
- 235000011852 gelatine desserts Nutrition 0.000 description 27
- 239000002245 particle Substances 0.000 description 24
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 22
- 239000000126 substance Substances 0.000 description 20
- 239000006185 dispersion Substances 0.000 description 19
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 18
- 239000003795 chemical substances by application Substances 0.000 description 16
- 206010070834 Sensitisation Diseases 0.000 description 14
- 239000007864 aqueous solution Substances 0.000 description 14
- 230000008313 sensitization Effects 0.000 description 14
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 13
- 239000011248 coating agent Substances 0.000 description 13
- 238000000576 coating method Methods 0.000 description 13
- 239000000084 colloidal system Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 230000001235 sensitizing effect Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 150000003839 salts Chemical group 0.000 description 10
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000004816 latex Substances 0.000 description 7
- 229920000126 latex Polymers 0.000 description 7
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 125000003710 aryl alkyl group Chemical group 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000011241 protective layer Substances 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 229920000139 polyethylene terephthalate Polymers 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 239000004848 polyfunctional curative Substances 0.000 description 5
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 5
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 235000010724 Wisteria floribunda Nutrition 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 4
- 229940116357 potassium thiocyanate Drugs 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 4
- 229910001961 silver nitrate Inorganic materials 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 4
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical group OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000002174 Styrene-butadiene Substances 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 150000008051 alkyl sulfates Chemical class 0.000 description 3
- 125000002947 alkylene group Chemical group 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 3
- 229920006317 cationic polymer Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000003851 corona treatment Methods 0.000 description 3
- 150000002391 heterocyclic compounds Chemical class 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 239000011970 polystyrene sulfonate Substances 0.000 description 3
- 229960002796 polystyrene sulfonate Drugs 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 229940001482 sodium sulfite Drugs 0.000 description 3
- 235000010265 sodium sulphite Nutrition 0.000 description 3
- 239000004328 sodium tetraborate Substances 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- 239000011115 styrene butadiene Substances 0.000 description 3
- 229920003048 styrene butadiene rubber Polymers 0.000 description 3
- NWRZGFYWENINNX-UHFFFAOYSA-N 1,1,2-tris(ethenyl)cyclohexane Chemical compound C=CC1CCCCC1(C=C)C=C NWRZGFYWENINNX-UHFFFAOYSA-N 0.000 description 2
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical class C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical class C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 description 2
- JAAIPIWKKXCNOC-UHFFFAOYSA-N 1h-tetrazol-1-ium-5-thiolate Chemical class SC1=NN=NN1 JAAIPIWKKXCNOC-UHFFFAOYSA-N 0.000 description 2
- HAZJTCQWIDBCCE-UHFFFAOYSA-N 1h-triazine-6-thione Chemical class SC1=CC=NN=N1 HAZJTCQWIDBCCE-UHFFFAOYSA-N 0.000 description 2
- LEJBBGNFPAFPKQ-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxy)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOC(=O)C=C LEJBBGNFPAFPKQ-UHFFFAOYSA-N 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 2
- CBHTTYDJRXOHHL-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridazine Chemical class N1=NC=CC2=C1N=NN2 CBHTTYDJRXOHHL-UHFFFAOYSA-N 0.000 description 2
- OWIRCRREDNEXTA-UHFFFAOYSA-N 3-nitro-1h-indazole Chemical class C1=CC=C2C([N+](=O)[O-])=NNC2=C1 OWIRCRREDNEXTA-UHFFFAOYSA-N 0.000 description 2
- OCVLSHAVSIYKLI-UHFFFAOYSA-N 3h-1,3-thiazole-2-thione Chemical compound SC1=NC=CS1 OCVLSHAVSIYKLI-UHFFFAOYSA-N 0.000 description 2
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 229920002085 Dialdehyde starch Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Chemical class 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 2
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- SJNALLRHIVGIBI-UHFFFAOYSA-N allyl cyanide Chemical compound C=CCC#N SJNALLRHIVGIBI-UHFFFAOYSA-N 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- JEHKKBHWRAXMCH-UHFFFAOYSA-N benzenesulfinic acid Chemical compound O[S@@](=O)C1=CC=CC=C1 JEHKKBHWRAXMCH-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 150000001565 benzotriazoles Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- GNTDGMZSJNCJKK-UHFFFAOYSA-N divanadium pentaoxide Chemical compound O=[V](=O)O[V](=O)=O GNTDGMZSJNCJKK-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine group Chemical group N1=CCC2=CC=CC=C12 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 2
- 229940006461 iodide ion Drugs 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- HBCQSNAFLVXVAY-UHFFFAOYSA-N pyrimidine-2-thiol Chemical class SC1=NC=CC=N1 HBCQSNAFLVXVAY-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003440 styrenes Chemical class 0.000 description 2
- 125000005504 styryl group Chemical group 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 150000003464 sulfur compounds Chemical class 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- JJJPTTANZGDADF-UHFFFAOYSA-N thiadiazole-4-thiol Chemical class SC1=CSN=N1 JJJPTTANZGDADF-UHFFFAOYSA-N 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- 125000005323 thioketone group Chemical group 0.000 description 2
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- LUMLZKVIXLWTCI-NSCUHMNNSA-N (e)-2,3-dichloro-4-oxobut-2-enoic acid Chemical compound OC(=O)C(\Cl)=C(/Cl)C=O LUMLZKVIXLWTCI-NSCUHMNNSA-N 0.000 description 1
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical class SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 description 1
- SIQZJFKTROUNPI-UHFFFAOYSA-N 1-(hydroxymethyl)-5,5-dimethylhydantoin Chemical compound CC1(C)N(CO)C(=O)NC1=O SIQZJFKTROUNPI-UHFFFAOYSA-N 0.000 description 1
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 1
- SAVMNSHHXUMFRQ-UHFFFAOYSA-N 1-[bis(ethenylsulfonyl)methoxy-ethenylsulfonylmethyl]sulfonylethene Chemical compound C=CS(=O)(=O)C(S(=O)(=O)C=C)OC(S(=O)(=O)C=C)S(=O)(=O)C=C SAVMNSHHXUMFRQ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Substances C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 1
- AMFYRKOUWBAGHV-UHFFFAOYSA-N 1h-pyrazolo[4,3-b]pyridine Chemical compound C1=CN=C2C=NNC2=C1 AMFYRKOUWBAGHV-UHFFFAOYSA-N 0.000 description 1
- LLCOQBODWBFTDD-UHFFFAOYSA-N 1h-triazol-1-ium-4-thiolate Chemical class SC1=CNN=N1 LLCOQBODWBFTDD-UHFFFAOYSA-N 0.000 description 1
- CISIJYCKDJSTMX-UHFFFAOYSA-N 2,2-dichloroethenylbenzene Chemical compound ClC(Cl)=CC1=CC=CC=C1 CISIJYCKDJSTMX-UHFFFAOYSA-N 0.000 description 1
- RSZXXBTXZJGELH-UHFFFAOYSA-N 2,3,4-tri(propan-2-yl)naphthalene-1-sulfonic acid Chemical compound C1=CC=CC2=C(C(C)C)C(C(C)C)=C(C(C)C)C(S(O)(=O)=O)=C21 RSZXXBTXZJGELH-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- BDOYKFSQFYNPKF-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;sodium Chemical compound [Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O BDOYKFSQFYNPKF-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- PHPYXVIHDRDPDI-UHFFFAOYSA-N 2-bromo-1h-benzimidazole Chemical class C1=CC=C2NC(Br)=NC2=C1 PHPYXVIHDRDPDI-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- AYPSHJCKSDNETA-UHFFFAOYSA-N 2-chloro-1h-benzimidazole Chemical class C1=CC=C2NC(Cl)=NC2=C1 AYPSHJCKSDNETA-UHFFFAOYSA-N 0.000 description 1
- SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- FLFWJIBUZQARMD-UHFFFAOYSA-N 2-mercapto-1,3-benzoxazole Chemical class C1=CC=C2OC(S)=NC2=C1 FLFWJIBUZQARMD-UHFFFAOYSA-N 0.000 description 1
- TURITJIWSQEMDB-UHFFFAOYSA-N 2-methyl-n-[(2-methylprop-2-enoylamino)methyl]prop-2-enamide Chemical compound CC(=C)C(=O)NCNC(=O)C(C)=C TURITJIWSQEMDB-UHFFFAOYSA-N 0.000 description 1
- KRTDQDCPEZRVGC-UHFFFAOYSA-N 2-nitro-1h-benzimidazole Chemical class C1=CC=C2NC([N+](=O)[O-])=NC2=C1 KRTDQDCPEZRVGC-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- UGWULZWUXSCWPX-UHFFFAOYSA-N 2-sulfanylideneimidazolidin-4-one Chemical compound O=C1CNC(=S)N1 UGWULZWUXSCWPX-UHFFFAOYSA-N 0.000 description 1
- NKJMNAMWEFRAIK-UHFFFAOYSA-N 2-sulfonyl-n-[2-[(2-sulfonylacetyl)amino]ethyl]acetamide Chemical compound O=S(=O)=CC(=O)NCCNC(=O)C=S(=O)=O NKJMNAMWEFRAIK-UHFFFAOYSA-N 0.000 description 1
- JSIAIROWMJGMQZ-UHFFFAOYSA-N 2h-triazol-4-amine Chemical class NC1=CNN=N1 JSIAIROWMJGMQZ-UHFFFAOYSA-N 0.000 description 1
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 description 1
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical compound ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 description 1
- WFFZGYRTVIPBFN-UHFFFAOYSA-N 3h-indene-1,2-dione Chemical compound C1=CC=C2C(=O)C(=O)CC2=C1 WFFZGYRTVIPBFN-UHFFFAOYSA-N 0.000 description 1
- NYYSPVRERVXMLJ-UHFFFAOYSA-N 4,4-difluorocyclohexan-1-one Chemical compound FC1(F)CCC(=O)CC1 NYYSPVRERVXMLJ-UHFFFAOYSA-N 0.000 description 1
- XOJWAAUYNWGQAU-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C(C)=C XOJWAAUYNWGQAU-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 description 1
- WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 239000005493 Chloridazon (aka pyrazone) Substances 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- ZFDIRQKJPRINOQ-HWKANZROSA-N Ethyl crotonate Chemical compound CCOC(=O)\C=C\C ZFDIRQKJPRINOQ-HWKANZROSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- GEIAQOFPUVMAGM-UHFFFAOYSA-N Oxozirconium Chemical compound [Zr]=O GEIAQOFPUVMAGM-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- ULQMPOIOSDXIGC-UHFFFAOYSA-N [2,2-dimethyl-3-(2-methylprop-2-enoyloxy)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(C)(C)COC(=O)C(C)=C ULQMPOIOSDXIGC-UHFFFAOYSA-N 0.000 description 1
- MMRSJZODOAQOTM-UHFFFAOYSA-N [4-(aminomethyl)phenyl]methanamine;dihydrochloride Chemical compound Cl.Cl.NCC1=CC=C(CN)C=C1 MMRSJZODOAQOTM-UHFFFAOYSA-N 0.000 description 1
- WOIHABYNKOEWFG-UHFFFAOYSA-N [Sr].[Ba] Chemical compound [Sr].[Ba] WOIHABYNKOEWFG-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- HGINCPLSRVDWNT-UHFFFAOYSA-N acrylaldehyde Natural products C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910001963 alkali metal nitrate Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 1
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 238000000498 ball milling Methods 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- WMUIZUWOEIQJEH-UHFFFAOYSA-N benzo[e][1,3]benzoxazole Chemical compound C1=CC=C2C(N=CO3)=C3C=CC2=C1 WMUIZUWOEIQJEH-UHFFFAOYSA-N 0.000 description 1
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- 125000006278 bromobenzyl group Chemical group 0.000 description 1
- INLLPKCGLOXCIV-UHFFFAOYSA-N bromoethene Chemical compound BrC=C INLLPKCGLOXCIV-UHFFFAOYSA-N 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 125000006226 butoxyethyl group Chemical group 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- WYKYKTKDBLFHCY-UHFFFAOYSA-N chloridazon Chemical compound O=C1C(Cl)=C(N)C=NN1C1=CC=CC=C1 WYKYKTKDBLFHCY-UHFFFAOYSA-N 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- NKKMVIVFRUYPLQ-NSCUHMNNSA-N crotononitrile Chemical compound C\C=C\C#N NKKMVIVFRUYPLQ-NSCUHMNNSA-N 0.000 description 1
- 125000004966 cyanoalkyl group Chemical group 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 1
- OIWOHHBRDFKZNC-UHFFFAOYSA-N cyclohexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1CCCCC1 OIWOHHBRDFKZNC-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- JBSLOWBPDRZSMB-FPLPWBNLSA-N dibutyl (z)-but-2-enedioate Chemical compound CCCCOC(=O)\C=C/C(=O)OCCCC JBSLOWBPDRZSMB-FPLPWBNLSA-N 0.000 description 1
- ZPFDRMZDXDVXOP-UHFFFAOYSA-N dibutyl 2-methylidenepropanedioate Chemical compound CCCCOC(=O)C(=C)C(=O)OCCCC ZPFDRMZDXDVXOP-UHFFFAOYSA-N 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- IEPRKVQEAMIZSS-AATRIKPKSA-N diethyl fumarate Chemical compound CCOC(=O)\C=C\C(=O)OCC IEPRKVQEAMIZSS-AATRIKPKSA-N 0.000 description 1
- 125000006182 dimethyl benzyl group Chemical group 0.000 description 1
- 150000002012 dioxanes Chemical class 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 150000002344 gold compounds Chemical class 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- UMGLBHQOFQXXSI-UHFFFAOYSA-N hepta-2,5-dienedioic acid Chemical compound OC(=O)C=CCC=CC(O)=O UMGLBHQOFQXXSI-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- AKCUHGBLDXXTOM-UHFFFAOYSA-N hydroxy-oxo-phenyl-sulfanylidene-$l^{6}-sulfane Chemical compound SS(=O)(=O)C1=CC=CC=C1 AKCUHGBLDXXTOM-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002545 isoxazoles Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000009607 mammography Methods 0.000 description 1
- 239000006224 matting agent Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- YDKNBNOOCSNPNS-UHFFFAOYSA-N methyl 1,3-benzoxazole-2-carboxylate Chemical compound C1=CC=C2OC(C(=O)OC)=NC2=C1 YDKNBNOOCSNPNS-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- ZAKLKBFCSHJIRI-UHFFFAOYSA-N mucochloric acid Natural products OC1OC(=O)C(Cl)=C1Cl ZAKLKBFCSHJIRI-UHFFFAOYSA-N 0.000 description 1
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical compound ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000004957 nitroimidazoles Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NZIDBRBFGPQCRY-UHFFFAOYSA-N octyl 2-methylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=C NZIDBRBFGPQCRY-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- KPCHOCIEAXFUHZ-UHFFFAOYSA-N oxadiazole-4-thiol Chemical class SC1=CON=N1 KPCHOCIEAXFUHZ-UHFFFAOYSA-N 0.000 description 1
- COWNFYYYZFRNOY-UHFFFAOYSA-N oxazolidinedione Chemical compound O=C1COC(=O)N1 COWNFYYYZFRNOY-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 1
- 229950005308 oxymethurea Drugs 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- HVAMZGADVCBITI-UHFFFAOYSA-M pent-4-enoate Chemical compound [O-]C(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-M 0.000 description 1
- ULDDEWDFUNBUCM-UHFFFAOYSA-N pentyl prop-2-enoate Chemical compound CCCCCOC(=O)C=C ULDDEWDFUNBUCM-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000005009 perfluoropropyl group Chemical group FC(C(C(F)(F)F)(F)F)(F)* 0.000 description 1
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 1
- XQYMIMUDVJCMLU-UHFFFAOYSA-N phenoxyperoxybenzene Chemical compound C=1C=CC=CC=1OOOC1=CC=CC=C1 XQYMIMUDVJCMLU-UHFFFAOYSA-N 0.000 description 1
- QIWKUEJZZCOPFV-UHFFFAOYSA-N phenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=CC=CC=C1 QIWKUEJZZCOPFV-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 description 1
- QTECDUFMBMSHKR-UHFFFAOYSA-N prop-2-enyl prop-2-enoate Chemical compound C=CCOC(=O)C=C QTECDUFMBMSHKR-UHFFFAOYSA-N 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical compound OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- KIWUVOGUEXMXSV-UHFFFAOYSA-N rhodanine Chemical compound O=C1CSC(=S)N1 KIWUVOGUEXMXSV-UHFFFAOYSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- IZWPGJFSBABFGL-GMFCBQQYSA-M sodium;2-[methyl-[(z)-octadec-9-enoyl]amino]ethanesulfonate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CCS([O-])(=O)=O IZWPGJFSBABFGL-GMFCBQQYSA-M 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000004964 sulfoalkyl group Chemical group 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- ZFDIRQKJPRINOQ-UHFFFAOYSA-N transbutenic acid ethyl ester Natural products CCOC(=O)C=CC ZFDIRQKJPRINOQ-UHFFFAOYSA-N 0.000 description 1
- 239000001003 triarylmethane dye Substances 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- KOZCZZVUFDCZGG-UHFFFAOYSA-N vinyl benzoate Chemical compound C=COC(=O)C1=CC=CC=C1 KOZCZZVUFDCZGG-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Abstract
Description
【発明の詳細な説明】
(従来技術)
近年、物理的に人体を切開することなく体の内部を観察
する方法は急速な進歩を遂げ、さらに発展し続けている
。CT、MRr、PET、超音波診断等の方法がそれで
あり、コンピューターによる画像処理はそれらの方法を
より診断能の高いシステムへと発展させ続けている。こ
れらの診断では1次的な画像はCRTで観察することに
なり1最影感材はCRTを直接撮影するか、コンピュー
ター内部にデジタル信号として取込まれた情報を半導体
レーザー露光で焼付ける等の方法で2次的にコピーされ
る。この目的のため、いわゆるCRT用感材感材−ザー
イメージヤ−用感材が急速に普及しつつある。DETAILED DESCRIPTION OF THE INVENTION (Prior Art) In recent years, methods for observing the inside of the human body without physically incising the body have made rapid progress and continue to develop. These include methods such as CT, MRr, PET, and ultrasonic diagnostics, and computer image processing continues to develop these methods into systems with higher diagnostic capabilities. In these diagnoses, the primary image is observed on a CRT, and the most sensitive material is either directly photographed on a CRT, or the information captured as a digital signal inside a computer is printed using semiconductor laser exposure. secondary copy by method. For this purpose, so-called CRT photosensitive materials (sensor imager photosensitive materials) are rapidly becoming popular.
しかしながら、医療・診断を目的とする撮影の8割から
9割は依然としてX線/螢光スクリーンとハロゲ゛ン化
銀惑材をもちいる云わゆるコンベンショナル・システム
に依存している。この方法は患者にとっても医師にとっ
ても簡便であり、導入および維持費が比較的安価である
こと。1次診断としてはかなり十分な情報かえられるこ
とから一部は他のシステムに置き変わるであろうが、将
来も主要な医療診断方法であると考えられる。However, 80% to 90% of imaging for medical and diagnostic purposes still relies on so-called conventional systems that use X-ray/fluorescent screens and silver halide recording materials. This method is convenient for both patients and physicians, and is relatively inexpensive to implement and maintain. Although some systems will likely be replaced by other systems as it can provide fairly sufficient information for primary diagnosis, it is thought that it will continue to be the main medical diagnostic method in the future.
米国では近年、女性の乳癌が急激に増加しており日本で
もその徴候がみられる。乳癌の早期発見方法としてX線
/螢光スクリーンと感材をもちいるコンベンショナル・
システムは極めて重要である。しかし乳癌の早期発見の
ためには数百μm程度の石灰化した病巣を識別する必要
があり、従来システムはこのため鮮鋭度を重視してシス
テム感度を犠牲にし、かなり多量のX線を診断のために
照射してきた。多量のX線照射が人体にとってを害であ
ることはいうまでもなく、このため被爆線量を軽減する
手段が求め続けられている。Breast cancer among women has been rapidly increasing in the United States in recent years, and signs of this are also seen in Japan. Conventional methods that use X-rays/fluorescent screens and sensitive materials as a method for early detection of breast cancer
Systems are extremely important. However, for early detection of breast cancer, it is necessary to identify calcified lesions of several hundred micrometers, and for this reason, conventional systems prioritize sharpness at the expense of system sensitivity, and use a considerably large amount of X-rays for diagnosis. I've been irradiating it for this purpose. It goes without saying that a large amount of X-ray irradiation is harmful to the human body, and for this reason, there continues to be a need for means to reduce the exposure dose.
Easttsan Kodak社はこの要求に対して
微細な固体状に分散した染料をクロスオーバー・カント
層として乳剤層の下層に塗布し、クロスオーバーによる
画像のボケを実質的にゼロにして片面スクリーン/感材
システムに近い鮮鋭度を有し、支持体の両側に感光性乳
剤層を有することで感度を大幅に向上させたマン上診断
用感材“TMM−1”を市場に提供した。この新技術の
詳細は米国特許第4.803,150号に開示されてい
る。しかしながら、この技術によって問題が解決したわ
けではない、依然として医師はより高鮮鋭度な画像を求
め、いまだに被爆線量の多い片面スクリーン/感材シス
テムがかなりの割合で使用されているのが現状である。In response to this demand, Easttsan Kodak Co., Ltd. applied dyes dispersed in fine solid form to the lower layer of the emulsion layer as a crossover cant layer. We have provided the market with a photosensitive material for manual diagnostics, "TMM-1," which has a sharpness close to that of the system, and has greatly improved sensitivity by having photosensitive emulsion layers on both sides of the support. Details of this new technology are disclosed in US Pat. No. 4,803,150. However, this technology has not solved the problem; doctors still demand higher-sharp images, and single-sided screens/sensitive material systems, which have a high exposure dose, are still used at a high rate. .
(本発明の目的)
本発明は前述の現状に対して、支持体の両側に感光性乳
剤層を有することで感度を大幅に向上させることによっ
て被爆線量の大幅な削減をはかり、かつ片面スクリーン
/感材システムを完全に凌恒する超高鮮鋭度な医療用X
線画像形成方法を提供することにあり、とくに乳癌検診
用として極めて有用な診断方法を提供することを目的と
する。(Objective of the present invention) The present invention solves the above-mentioned current situation by providing a photosensitive emulsion layer on both sides of the support to significantly improve the sensitivity and thereby significantly reduce the exposure dose. Ultra-high sharpness medical X that completely surpasses sensitive material systems
It is an object of the present invention to provide a line image forming method, and particularly to provide an extremely useful diagnostic method for breast cancer screening.
(本発明を達成する手段)
本発明の上記目的は以下の方法により達成された。即ち
、透明支持体の両側にそれぞれ少なくとも一層の感光性
ハロゲン化銀乳剤層を有する医療用写真感光材料を現像
処理する方法において、該写真感光材料のクロスオーバ
ー光が12%以下であるように乳剤層および/またはク
ロスオーバーカット層を調製し、該医療用X線画像形成
フィルムのハロゲン化銀乳剤の現像進行状態がいわゆる
パラレル型(parallel fashion )
現像となるように現像処理することにより目的を達成し
た。(Means for Achieving the Present Invention) The above objects of the present invention were achieved by the following method. That is, in a method for developing a medical photographic light-sensitive material having at least one light-sensitive silver halide emulsion layer on each side of a transparent support, the emulsion is processed so that the cross-over light of the photographic light-sensitive material is 12% or less. layer and/or crossover cut layer, and the development progress state of the silver halide emulsion of the medical X-ray imaging film is in a so-called parallel fashion.
The purpose was achieved by developing the image.
本発明でいうところの、いわゆるパラレル型(para
llel fashion )現像とはC,E、 K
ennethMees およびT、 Il、 Jam
es 著’ TIIE THEORY 0FTtlE
PH0TOGRAPHICPROCESS T旧
RD EDITION(Macmillan社刊 )
″の333ページやT、 II。In the present invention, so-called parallel type (parallel type)
llel fashion) development is C, E, K
ennethMees and T, Il, Jam
Written by es' TIIE THEORY 0FTtlE
PH0TOGRAPHIC PROCESS T old RD EDITION (published by Macmillan)
”, page 333, T, II.
Jalmesの論文” JournaI of Ph1
sical Chemistry土土、42(1940
)”に記載されている。Jalmes' paper "JournaI of Ph1
sical Chemistry Do Do, 42 (1940
)"It is described in.
また、笹井 明 著“写真の化学(写真工業出版社刊)
°°の221ページには(1)現像された銀粒子の平均
の大きさが増加する・・・すなわち現像されつつある粒
子が、しだいに全体が現像されてくる場合と(2)現像
された粒子の数が増加する場合の2種類の現像過程の考
え方が示されており、本発明のパラレル型(paral
lel fashion )現像とは前者(1)の現
像過程が(2)の過程に対して高い割合いで存在する現
像過程を意味する。本発明においては、乳剤層中のすべ
ての粒子が同時に現像を開始し、現像時間の増加による
濃度の増加が単に現像銀粒子の大きさの増加によるもの
であり現像銀の数は同しになることがもっとも1思的な
状態であり、できるかぎりこの状態に近いほど本発明の
効果は顕著である。In addition, Akira Sasai, “Chemistry of Photography” (published by Shashin Kogyo Publishing)
Page 221 of °° states that (1) the average size of the developed silver particles increases...that is, the particles that are being developed gradually become fully developed; and (2) the average size of the developed silver particles increases. Two types of development process concepts are shown when the number of particles increases, and the parallel type (parallel type) of the present invention
(lel fashion) Development means a development process in which the former (1) development process exists at a higher rate than the (2) process. In the present invention, all the grains in the emulsion layer start developing at the same time, and the increase in density due to the increase in development time is simply due to an increase in the size of the developed silver particles, and the number of developed silver remains the same. This is the most thought-provoking state, and the closer to this state as possible, the more significant the effects of the present invention will be.
最近では、1987年のICPS (Kol n)にて
H,J、Metzが′異なる現像液系でのハロゲン化銀
結晶の還元のa構“°について発表しており、そのなか
で上記の現象について論じた。また、1987年度日本
写真学会秋期大会において、三重・山水・谷らはハロゲ
ン化銀乳剤の性質が現像速度にあたえる影響について発
表しており、そのなかで前述の(1)、(2)の現像過
程をそれぞれパラレル現像、グラニュラ−現像として定
義し議論を展開した。Recently, in 1987 at ICPS (Kol n. Furthermore, at the 1987 Autumn Conference of the Photographic Society of Japan, Mie, Sansui, and Tani et al. gave a presentation on the influence of the properties of silver halide emulsions on development speed, and included the above-mentioned (1) and (2). ) development processes were defined as parallel development and granular development, respectively, and a discussion was developed.
本発明においては、本発明のシステムで十分な露光を与
た感材を現像処理した時の最高到達濃度(Dmax)と
未露光で処理した時の濃度(Fog)のl/34度(−
(Dma x+Fo g)X l/31において、現像
途中にあるハロゲン化根粒子の総数が現像が完了したハ
ロゲン化銀粒子の総数の少なくとも同数以上1000倍
以下、好ましくは】0倍以上500倍以下、特に50倍
以上200倍以下であることを特徴とする。In the present invention, the maximum density (Dmax) obtained when a sensitive material sufficiently exposed to light is developed using the system of the present invention and the density (Fog) obtained when processed without exposure are 1/34 degrees (-
(Dmax + Fo g) In particular, it is characterized by being 50 times or more and 200 times or less.
本発明のパラレル型現像が実現できたかどうかの確認は
、乳剤をかさなりが無いように薄層塗布した系の現像途
中にある粒子を光学顕微鏡で直接観察するか、現像の途
中で低いPHの現像停止液につけたり、液体窒素温度に
2.激に冷却したりすることで現像を停止させ、しかる
のちにハロゲン化銀粒子を親水性コロイド層よりとりだ
して電子顕微鏡で観察することで容易にT11認しうる
。To confirm whether the parallel development of the present invention has been achieved, directly observe the particles in the process of development using an optical microscope in a system in which the emulsion is coated in a thin layer so that there is no bulk, or by performing low pH development in the middle of development. 2. Soak in stop solution or at liquid nitrogen temperature. T11 can be easily recognized by stopping the development by intense cooling, and then taking out the silver halide grains from the hydrophilic colloid layer and observing them with an electron microscope.
本発明のパラレル型現像を実現する手段としては、まず
パラレル型現像となりやすい現像液を利用することが考
えられる。このような現像液としては、市販のカラーペ
ーパー用現像液CP20(富士写真フィルム(株)製)
や一般白黒ネガ現像液D76などが知られている。これ
らの現像液の処理条件はCP2Oの場合33°Cで3分
30秒、D76では20°C4分または7分が一般でき
であるが、本発明においては現像液のPHを10.5〜
12程度に高めたり、処理温度を30〜40″Cに高め
たり、あるいはこれらの方法を組合わせる等の方法で感
度を維持しながら現像処理時間を60秒以下にすること
が、高画質を実現する上でも処理の迅速化を達成する上
でも有用な方法である。As a means for realizing the parallel type development of the present invention, first, it is possible to use a developer that easily causes parallel type development. As such a developer, commercially available developer for color paper CP20 (manufactured by Fuji Photo Film Co., Ltd.) is used.
and general black and white negative developer D76. The processing conditions for these developers are generally 3 minutes and 30 seconds at 33°C for CP2O and 4 or 7 minutes at 20°C for D76, but in the present invention, the pH of the developer is set to 10.5 to 10.5.
High image quality can be achieved by reducing the development processing time to 60 seconds or less while maintaining sensitivity by raising the processing temperature to around 12"C, raising the processing temperature to 30-40"C, or combining these methods. This is a useful method both for speeding up processing and for speeding up processing.
一方、医療用X−ray感材の処理剤として通常使用さ
れているXomat RP Developer (E
asttsanKodak社製)、RD[[IやHi
RENDOL (いずれも富士写真フィルム(株)社製
)は、はとんどパラレル型(Parallel fa
shton )現像の特徴をしめさない、しかし、この
ような現像液においても感光性乳剤層にもちいるハロゲ
ン化銀粒子のハロゲン組成のAgl含量を6モル%以上
にすれば本発明のパラレル型(Parallel f
ashion )現像を実現することができる。On the other hand, Xomat RP Developer (E
asttsanKodak), RD [[I and Hi
RENDOL (both manufactured by Fuji Photo Film Co., Ltd.) is mostly parallel type (Parallel fa).
However, even in such a developer, the parallel type ( Parallel f
ashion) development can be realized.
特開昭63−73244号にはAgl含量が3゜0〜1
5.1モル%のAgBr+平板粒子を用いて本発明の効
果の一部を発現させる方法が記載されているが、該発明
はクロスオーバーカットに関しては不十分であり本発明
の効果を達成できていない。JP-A No. 63-73244 has an Agl content of 3°0 to 1.
Although a method for achieving some of the effects of the present invention using 5.1 mol% AgBr + tabular grains is described, this invention is insufficient in terms of crossover cut and cannot achieve the effects of the present invention. do not have.
本発明の感光材料の写真処理には、例えばリサーチ・デ
ィスクロージャ−176号第28〜30頁(RD−17
643)に記載されているような、黒白写真処理の公知
の方法及び公知の処理液のいずれをも適用することがで
きる。処理温度は普通18°Cから50″Cの間に選ば
れるが、18°Cより低い温度または50°Cを越える
温度としてもよいが本発明には30〜45゛Cでの自動
現像機による迅速処理が特に好ましい、現像主薬として
は、ジヒドロキシベンゼン!I(たとえばハイドロキノ
ン)、3−ピラゾリドン類(たとえば1−フェニル−3
−ビラゾリドン)、アミノフェノールl![(たとえば
N−メチル−P−アミノフェノールなどを単独もしくは
組合せて用いることができる。現像液には一般にこの他
公知の保恒剤、アルカリ剤、pH緩衝剤、カブリ防止剤
などを含み、さらに必要に応じ溶解助剤、色調剤、現像
促進剤(例えば、4級塩、ヒドラジン、ベンジルアルコ
ール)、界面活性剤、消泡剤、硬水軟化剤、硬膜剤(例
えば、グルタルアルデヒド)、粘性付与剤などを含んで
もよい。For example, Research Disclosure No. 176, pages 28-30 (RD-17
Any of the known methods and known processing solutions for black-and-white photographic processing, such as those described in 643), can be applied. The processing temperature is normally selected between 18°C and 50"C, but temperatures below 18°C or above 50"C may also be used, although in the present invention an automatic processor at 30-45°C is used. Developing agents for which rapid processing is particularly preferred include dihydroxybenzene!I (e.g. hydroquinone), 3-pyrazolidones (e.g. 1-phenyl-3
- vilazolidone), aminophenol l! [(For example, N-methyl-P-aminophenol and the like can be used alone or in combination. The developer generally contains other known preservatives, alkaline agents, pH buffers, antifoggants, etc. If necessary, solubilizing agent, color toning agent, development accelerator (e.g. quaternary salt, hydrazine, benzyl alcohol), surfactant, antifoaming agent, water softener, hardener (e.g. glutaraldehyde), viscosity imparting agent. It may also contain agents.
現像処理の特殊な形式として、現像主薬を感光材料中、
たとえば乳剤層中に含み、感光材料をアルカリ水溶液中
で処理して現像を行なわせる方法を用いてもよい、現像
主薬のうち、疎水性のものは、リサーチディスクロージ
ャ16゛9号(RD−16928)、米国特許第2,7
39,890号、英国特許第813,253号又は西独
国特許第17547.763号などに記載の種々の方法
で乳剤層中に含ませることができる。このような現像処
理は、チオシアン酸塩による銀塩安定化処理と組合せて
もよい。As a special form of development processing, a developing agent is added to the light-sensitive material.
For example, hydrophobic developing agents that are contained in the emulsion layer and may be developed by processing the light-sensitive material in an alkaline aqueous solution are disclosed in Research Disclosure No. 16-9 (RD-16928). , U.S. Patent No. 2,7
39,890, British Patent No. 813,253 or West German Patent No. 17547.763. Such development treatment may be combined with silver salt stabilization treatment with thiocyanate.
定着液としては一般に用いられる組成のものを用いるこ
とができる。定着剤としてはチオ硫酸塩、チオシアン酸
塩のほか、定着剤としての効果が知られている有機硫黄
化合物を用いることができる。As the fixer, one having a commonly used composition can be used. As the fixing agent, in addition to thiosulfates and thiocyanates, organic sulfur compounds known to be effective as fixing agents can be used.
定着液には硬膜剤として水溶性アルミニウム塩を含んで
もよい。The fixing solution may contain a water-soluble aluminum salt as a hardening agent.
本発明に用いられる感光性ハロゲン化銀乳剤としては、
塩化銀、塩臭化銀、臭化銀、沃臭化銀、塩沃臭化銀を用
いることができるが前述の現像液との組み合わせで次の
ような組み合わせが高感度という観点で好ましい、ピラ
ゾン−ヒドロキノン系の現像液においては沃臭化銀また
は塩沃臭化銀が好ましく、特に法度含量が411oI1
%〜20+*of%が好ましい、一方、メト−ルーヒド
ロキノン系の現像液においては沃度含量6moJ!%以
下好ましくは3■o1%以下の沃臭化銀、純臭化銀、塩
臭化銀が好ましく、沃臭化銀においては内部に高沃度相
を有する構造の粒子が特に好ましい。The photosensitive silver halide emulsion used in the present invention includes:
Silver chloride, silver chlorobromide, silver bromide, silver iodobromide, and silver chloroiodobromide can be used, but the following combinations with the aforementioned developer are preferred from the viewpoint of high sensitivity: Pyrazone - In the hydroquinone-based developer, silver iodobromide or silver chloroiodobromide is preferable, especially when the legal content is 411oI1
% to 20+*of% is preferred, while in metho-hydroquinone-based developers the iodine content is 6 moJ! % or less, preferably 3.0% or less, silver iodobromide, pure silver bromide, and silver chlorobromide are preferred, and among silver iodobromide, grains having a structure having a high iodine phase inside are particularly preferred.
また、特開昭60−230135号や同63−2565
3号に記載されているような、現像時に抑制剤を放出す
るような化合物を併用すると本発明の効果はさらに好ま
しいものとなる。Also, JP-A-60-230135 and JP-A No. 63-2565
The effect of the present invention becomes even more favorable when a compound that releases an inhibitor during development, as described in No. 3, is used in combination.
クロスオーバー光が鮮鋭度を大巾に低下させることは当
業界では周知の事実である。It is a well-known fact in the art that crossover light significantly reduces sharpness.
写真感光材料のクロスオーバー光が12%以下であるよ
うにする手段としては、米国特許US4゜130.42
9、特開昭61−116354などにX線螢光スクリー
ンの発光波長と一致する波長の光を増感色素や染料をも
ちいて吸収する方法が開示されている。As a means for ensuring that the cross-over light of photographic light-sensitive materials is 12% or less, US Patent No. 4°130.42
9, JP-A-61-116354, etc. discloses a method of absorbing light with a wavelength matching the emission wavelength of an X-ray fluorescent screen using a sensitizing dye or dye.
さらに、米国特許US4,803,150には支持体と
乳剤層の間に染料を微結晶分散物の形として存在させク
ロスオーバi光が10%以下であるようにする技術が開
示されている。また、特願昭62−141111にはカ
チオン性ポリマーラテックスを用いてアニオン性染料を
特定層に固定する技術が、さらに特願昭62−3245
75には染料の固定層を支持体の下塗り層にする技術が
開示されている0本発明の感材はこれらのいずれの方法
をも用いることができるが、染料による着色層は下塗り
層であることが好ましく染料は特願昭62−32457
5記載の方法で固定されていること、特に染料がUS4
,803,150記載の微結晶分散物のかたちで下塗り
層に固定されていることが望ましい。Further, US Pat. No. 4,803,150 discloses a technique in which a dye is present in the form of a microcrystalline dispersion between a support and an emulsion layer so that the cross-over i-light is less than 10%. In addition, Japanese Patent Application No. 62-141111 describes a technique for fixing anionic dyes in a specific layer using cationic polymer latex, and Japanese Patent Application No. 62-3245
No. 75 discloses a technique in which the dye fixed layer is used as an undercoat layer on the support.0 The sensitive material of the present invention can use any of these methods, but the dye-colored layer is an undercoat layer. Preferably, the dye is disclosed in Japanese Patent Application No. 62-32457.
5. In particular, the dye must be fixed by the method described in US 4.
It is preferable that it is fixed to the undercoat layer in the form of a microcrystalline dispersion as described in , 803, 150.
本発明ではこれらの方法を適宜組合わせることが可能で
ある。In the present invention, these methods can be combined as appropriate.
本発明に好ましく用いられる染料の微結晶粒子形態の分
散物層としては一般式(1)、(II)、(I[[)、
(IV)又は(V)で表わされる化合物の微結晶分散体
のフィルター染料層が用いられる。The dispersion layer of the dye in the form of microcrystalline particles preferably used in the present invention includes general formulas (1), (II), (I[[),
A filter dye layer of a microcrystalline dispersion of a compound of (IV) or (V) is used.
−紋穴N)
R1
S
一般式(n)
R1
cs
一般式(I[I)
A =L + + L z −L s ÷1−A’
一般式(IV)
A+L+ L!→T1B
一般式(V)
式中A SA ’はカルボキシフェニル基、スルファモ
イル基またはスルホンアミドフェニル基をもつ置換もし
くは無置換の酸性核を表わす、酸性核としては2−ビラ
プリン−5−オン、ロダニン、ヒダントイン、チオヒダ
ントイイ、2,4−オキサゾリジンジオン、イソオキサ
シリノン、バルビッル酸、チオバルビッル酸、インダン
ジオン、ピラゾロピリジン、ヒドロキシピリドンから選
ばれる。Bはカルボキシル基、スルファモイル基もしく
はスルホンアミド基をもつ置換あるいは無置換の塩基性
核を表わす、塩基性核としてはピリジン、キノリン、イ
ンドレニン、オキサゾール、ペンヅオキサゾール、ナフ
トオキサゾール、ピロールからなる群から選ばれる。R
は水素原子、炭素数1〜5のアルキル、R+、Rzは各
々、置換もしくは無置換のアルキル基、置換もしくは無
置換のアリール基、アシル基でR3とRtが炭素原子で
5〜6員環を形成してもよい、Rs 、Rhは水素原子
、ヒドロキシ基、カルボキシ基、アルキル基、アルコキ
シ基、又はハロゲン原子をあられし、R4、R1は各々
水素原子又はR1とR4あるいはR8とR3で5〜6員
環を形成するのに必要な金属原子群をあられす、Ll、
Lt、、L、は各々置換もしくは無置換のメチン基を表
わす、x、yは各々電子吸引性基を表わしX、Yのいず
れかに少なくとも1個のカルボキシフェニル基、もしく
はスルファモイルフェニル基、スルホンアミドフェニル
基をもつ1mは0もしくは1を表わし、nは011もし
くは2を表わす、Pは0、または1をあられす。- Pattern hole N) R1 S General formula (n) R1 cs General formula (I [I) A = L + + L z -L s ÷1-A'
General formula (IV) A+L+ L! →T1B General formula (V) In the formula, A SA ' represents a substituted or unsubstituted acidic nucleus having a carboxyphenyl group, sulfamoyl group, or sulfonamidophenyl group, and examples of the acidic nucleus include 2-viraprin-5-one, rhodanine, selected from hydantoin, thiohydantoin, 2,4-oxazolidinedione, isoxacillinone, barbital acid, thiobarbic acid, indandione, pyrazolopyridine, and hydroxypyridone. B represents a substituted or unsubstituted basic nucleus having a carboxyl group, sulfamoyl group, or sulfonamide group; the basic nucleus is selected from the group consisting of pyridine, quinoline, indolenine, oxazole, penduoxazole, naphthoxazole, and pyrrole; To be elected. R
is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, R+ and Rz are each a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, or an acyl group, and R3 and Rt are carbon atoms forming a 5- to 6-membered ring. Rs and Rh each represent a hydrogen atom, a hydroxy group, a carboxy group, an alkyl group, an alkoxy group, or a halogen atom, and R4 and R1 each represent a hydrogen atom, or R1 and R4 or R8 and R3 each represent a Hail the metal atoms necessary to form a 6-membered ring, Ll,
Lt, L each represent a substituted or unsubstituted methine group, x and y each represent an electron-withdrawing group, and either X or Y has at least one carboxyphenyl group or a sulfamoylphenyl group, 1m having a sulfonamidophenyl group represents 0 or 1, n represents 011 or 2, and P represents 0 or 1.
次に本発明に用いられる染料の具体例を挙げるが、本発
明はこれらに限定されるものではない。Next, specific examples of dyes used in the present invention will be given, but the present invention is not limited thereto.
[−7
■−11
■−12
!
■−13
H3
■−14
■−15
■−16
■−17
しtI3
m−3
■
■−5
■−6
■−8
+11−9
■−1
ctt’s
■
C,lIs
V−9
Ct 11 s
zHs
■−12
V−5
C鵞H5
H3
V−8
■−13
■−15
Cz It s
■−16
V−4
■−1
C2H4
Js
CHl
CHl
本発明に用いられる染料は国際特許出願公開(WO)8
B104794号、ヨーロッパ特許(BP)02747
23A1号、特開昭52−92716号、同55−15
5350号、同55−1、 5 5 3 5 1号、同
61−205934号、同4B−68623号、米国特
許第2527583号、同3486897号、同374
6539号、同3933798号、同4130429号
、同4040841号等に記載された方法およびその方
法に準じて容易に合成することができる。[-7 ■-11 ■-12! ■-13 H3 ■-14 ■-15 ■-16 ■-17 ShitI3 m-3 ■ ■-5 ■-6 ■-8 +11-9 ■-1 ctt's ■ C,lIs V-9 Ct 11 s zHs ■-12 V-5 Cen H5 H3 V-8 ■-13 ■-15 Cz It s ■-16 V-4 ■-1 C2H4 Js CHl CHl The dye used in the present invention is disclosed in the International Patent Application Publication (WO) 8
B104794, European Patent (BP) 02747
No. 23A1, JP-A-52-92716, JP-A No. 55-15
No. 5350, No. 55-1, No. 55351, No. 61-205934, No. 4B-68623, U.S. Patent No. 2527583, No. 3486897, No. 374
It can be easily synthesized by the methods described in No. 6539, No. 3933798, No. 4130429, No. 4040841, and the like.
本発明で有用な染料は、光を吸収するために有用な量で
使用できるが、それらが現像処理の間に可溶化され洗出
されるような量及び位置でそれらを使用することが特に
有利である.少量の光だけを吸収することが望ましい場
合には、少量の染料だけが必要である.より大量の光を
吸収することが望ましい場合には、着色レベルが特別の
写真要素にとって受は入れられるレベルで残留している
限りより大量の染料が使用できる.染料は、好ましくは
、片面あたり10〜1000■/ポの量で写真要素中に
存在する。Although the dyes useful in this invention can be used in any useful amount to absorb light, it is particularly advantageous to use them in amounts and locations such that they are solubilized and washed out during the development process. be. If it is desired to absorb only a small amount of light, only a small amount of dye is needed. If greater amounts of light absorption are desired, larger amounts of dye can be used as long as the coloration level remains acceptable for the particular photographic element. The dye is preferably present in the photographic element in an amount of 10 to 1000 cm/po per side.
本発明で有用な染料は、写真要素上に被覆される親水性
コロイド層のような層の中に含有させるために、固体粒
子微結晶分散体の形状である.微結晶分散体は、分散体
の形状に染料を沈澱させること、及び/又は分散剤の存
在下に、公知の粉砕方法、例えばボールミル粉砕、サン
ドミル粉砕又はコロイドミル粉砕によって、形成できる
.分散体中の染料粒子は、10μm未満、より好ましく
は、1μm未満、特に好ましくは0.3μm未満の平均
径を有する。The dyes useful in this invention are in the form of solid particulate microcrystalline dispersions for inclusion in layers, such as hydrophilic colloid layers, coated on photographic elements. Microcrystalline dispersions can be formed by precipitating the dye in the form of a dispersion and/or by known milling methods, such as ball milling, sand milling or colloid milling, in the presence of a dispersant. The dye particles in the dispersion have an average diameter of less than 10 μm, more preferably less than 1 μm, particularly preferably less than 0.3 μm.
本発明の媒染層は、脱色性の良いアニオン染料と媒染剤
としてのカチオンポリマーを主要素材として含み、下記
−紋穴(Vl)のカチオンポリマーと一般のアニオン染
料の組み合わせが好ましく用いられる.染料と媒染剤の
結合物を安定に塗布するには、工夫が必要である.媒染
層を支持体と感光性乳剤層との間の層として、感光性乳
剤層と同時塗布する場合はその中間にできるだけ不要な
アニオンを含まない中間層を設けることで良好な塗宿性
が得られる。又支持体下塗り層中に該結合物を添加し、
安定で良好な下塗り面状を維持するには、ノニオン界面
活性剤を併用すると良い。The mordant layer of the present invention contains an anionic dye with good decolorizing properties and a cationic polymer as a mordant as main materials, and a combination of a cationic polymer and a general anionic dye as shown below (Vl) is preferably used. In order to stably apply the combination of dye and mordant, some ingenuity is required. When the mordant layer is used as a layer between the support and the photosensitive emulsion layer and is coated simultaneously with the photosensitive emulsion layer, good coating properties can be obtained by providing an intermediate layer containing as little unnecessary anions as possible between the mordant layer and the photosensitive emulsion layer. It will be done. Also, adding the binder to the undercoat layer of the support,
In order to maintain a stable and good undercoat surface condition, it is recommended to use a nonionic surfactant in combination.
−紋穴(Vl)
R9
−(−A h −+ CHz −c 汁 → B
)tL Xo
Rt Q Rs
式中Aはエチレン性不飽和七ツマー単位を表わす、R1
は水素原子または炭素数1〜約6の低級アルキル基を、
Lは1〜約12個の炭素原子を有する二価基を表わす−
Rt 、RsおよびR4はそれぞれ同一または異種の1
〜約20個の炭素原子を有するアルキル基、もしくは7
〜約20個の炭素原子を有するアラルキル基または水素
原子を表わし、Rg 、Rs及びR4は相互に連結して
Qとともに環状構造を形成してもよい、好ましくはR1
、Rj 、R,のうち1つのみが水素原子である。Qは
NまたはPであり、Xoは沃素イオン以外のアニオンを
表わす。- Monka (Vl) R9 -(-A h -+ CHz -c Juice → B
)tL Xo Rt Q Rs In the formula, A represents an ethylenically unsaturated heptamer unit, R1
is a hydrogen atom or a lower alkyl group having 1 to about 6 carbon atoms,
L represents a divalent group having 1 to about 12 carbon atoms -
Rt, Rs and R4 are each the same or different 1
an alkyl group having ~20 carbon atoms, or 7
represents an aralkyl group or a hydrogen atom having ~20 carbon atoms, Rg, Rs and R4 may be interconnected to form a cyclic structure with Q, preferably R1
, Rj and R, only one is a hydrogen atom. Q is N or P, and Xo represents an anion other than iodide ion.
Aのエチレン性不飽和七ツマ−の例としては、たとえば
オレフィン類(たとえば、エチレン、プロピレン、1−
ブテン、塩化ビニル、塩化ビニリデン、イソブチン、臭
化ビニルなど)、ジエン類(たとえばブタジェン、イソ
プレン、クロロブレンなど)、脂肪酸又は芳香族カルボ
ン酸のエチレン性不飽和エステル(たとえば酢酸ビニル
、酢酸アリル、ビニルプロピオネート、ビニルブチレー
ト、安息香酸ビニルなど)、エチレン性不飽和酸のエス
テル(たとえば、メチルメタクリレート、ブチルメタク
リレート、tert−ブチルメタクリレート、シクロヘ
キシルメタクリレート、ベンジルメタクリレート、フェ
ニルメタクリレート、オクチルメタクリレート、アミル
アクリレート、2−エチルへキシルアクリレート、ベン
ジルアクリレート、マレイン酸ジブチルエステル、フマ
ル酸ジエチルエステル、クロトン酸エチル、メチレンマ
ロン酸ジブチルエステルなど)、スチレン類(たとえば
、スチレン、α−メチルスチレン、ビニルトルエン、ク
ロルメチルスチレン、クロルスチレン、ジクロルスチレ
ン、ブロムスチレン、など)、不飽和ニトリル(たとえ
ばアクリロニトリル、メタクリレートリル、シアン化ア
リル、クロトンニトリルなど)がある、この中でも、乳
化重合性、疎水性等の点からスチレン類、メタクリル酸
エステル類が特に好ましい6Aは上記モノマーの2種以
上を含んでもよい。Examples of the ethylenically unsaturated heptamers of A include olefins (e.g., ethylene, propylene, 1-
butene, vinyl chloride, vinylidene chloride, isobutyne, vinyl bromide, etc.), dienes (e.g. butadiene, isoprene, chlorobrene, etc.), ethylenically unsaturated esters of fatty acids or aromatic carboxylic acids (e.g. vinyl acetate, allyl acetate, vinyl pionate, vinyl butyrate, vinyl benzoate), esters of ethylenically unsaturated acids (e.g. methyl methacrylate, butyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, benzyl methacrylate, phenyl methacrylate, octyl methacrylate, amyl acrylate, - ethylhexyl acrylate, benzyl acrylate, dibutyl maleate, diethyl fumarate, ethyl crotonate, dibutyl methylenemalonate, etc.), styrenes (e.g., styrene, α-methylstyrene, vinyltoluene, chloromethylstyrene, Chlorstyrene, dichlorostyrene, bromstyrene, etc.), unsaturated nitriles (e.g. acrylonitrile, methacrylaterile, allyl cyanide, crotonitrile, etc.). Among these, styrenes, 6A, which is particularly preferably a methacrylic acid ester, may contain two or more of the above monomers.
R1は、重合反応性などの点から水素原子またはメチル
基が好ましい。R1 is preferably a hydrogen atom or a methyl group from the viewpoint of polymerization reactivity.
く、耐アルカリ性などの点から−C−N−R,−上式に
於いてRsは、アルキレン(例えばメチレン、エチレン
、トリメチレン、テトラメチレンなと)、アニーレン、
アラルキレン(例えば原子を有するアルキレン)を表わ
し、R6は水素原子またはR1を表わす、nは1また2
の整数である。From the viewpoint of alkali resistance, -C-N-R, - in the above formula, Rs is alkylene (for example, methylene, ethylene, trimethylene, tetramethylene), annealed,
represents an aralkylene (e.g. alkylene having an atom), R6 represents a hydrogen atom or R1, n is 1 or 2
is an integer.
Qは原料の有害性などの点からNが好ましい。Q is preferably N in view of the toxicity of the raw material.
X(Elは沃素イオン以外のアニオンであり例えばハロ
ゲンイオン(たとえば塩素イオン、臭素イオン、など)
、アルキル硫酸イオン(たとえばメチル硫酸イオン、エ
チル硫酸イオンなど)、アルキル或いはアリールスルホ
ン酸イオン(たとえばメタンスルホン酸、エタンスルホ
ン酸、ベンゼンスルホン酸、p−トルエンスルホン酸な
ど)、硝酸イオン、酢酸イオン、硫酸イオンなどがある
。これらの中でも塩素イオン、アルキル硫酸イオン、ア
リールスルホン酸イオン、硫酸イオンが特に好ましい。X (El is an anion other than iodide ion, such as halogen ion (e.g. chloride ion, bromide ion, etc.)
, alkyl sulfate ions (e.g. methyl sulfate ion, ethyl sulfate ion, etc.), alkyl or aryl sulfonate ions (e.g. methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, etc.), nitrate ion, acetate ion, Contains sulfate ions. Among these, chloride ions, alkyl sulfate ions, arylsulfonate ions, and sulfate ions are particularly preferred.
R,、R,及びR1のアルキル基およびアラルキル基に
は置換アルキル基および置換アラルキル基が含まれる。The alkyl groups and aralkyl groups of R, R, and R1 include substituted alkyl groups and substituted aralkyl groups.
アルキル基としては無置換アルキル基、たとえば、メチ
ル基、エチル基、プロピル基、イソプロピル基、t−ブ
チル基、ヘキシル基、シクロヘキシル基、2−エチルヘ
キシル基、ドデシル基など、置換アルキル基たとえばア
ルコキシアルキル基(たとえば、メトキシメチル基、メ
トキシブチル基、エトキシエチル基、ブトキシエチル基
、ビニロキシエチル基など)、シアノアルキル基(たと
えば2−シアノエチル基、3−シアノプロピル基など)
、ハロゲン化アルキル基(たとえば、2フルオロエチル
基、2−クロロエチル基、パーフロロプロピル基など)
、アルコキシカルボニルアルキル基(たとえば、エトキ
シカルボニルメチル基など)、アリル基、2−ブテニル
基、プロパキル基などがある。Examples of alkyl groups include unsubstituted alkyl groups, such as methyl, ethyl, propyl, isopropyl, t-butyl, hexyl, cyclohexyl, 2-ethylhexyl, and dodecyl groups; substituted alkyl groups, such as alkoxyalkyl groups; (e.g., methoxymethyl group, methoxybutyl group, ethoxyethyl group, butoxyethyl group, vinyloxyethyl group, etc.), cyanoalkyl group (e.g., 2-cyanoethyl group, 3-cyanopropyl group, etc.)
, halogenated alkyl group (e.g., 2-fluoroethyl group, 2-chloroethyl group, perfluoropropyl group, etc.)
, an alkoxycarbonylalkyl group (for example, an ethoxycarbonylmethyl group), an allyl group, a 2-butenyl group, a propakyl group, and the like.
アラルキル基としては、=、WIAアラルキル法、たと
えば、ベンジル基、フェネチル基、ジフェニルメチル基
、ナフチルメチル基など、1f喚アラルキル基、たとえ
ばアルキルアラルキル基(たとえば、4−メチルベンジ
ル基、2.5−ジメチルベンジル基、4−イソプロピル
ヘンシル基、4−オクチルベンジル基など)、アルコキ
シアラルキル基(たとえば、4−メトキシベンジル基、
4−ペンタフロロプロペニルオキシベンジル基、4−エ
トキシベンジル基など)、シアノアラルキル基(たとえ
ば4−シアノヘンシル基、4−(4−シアノフェニル)
ベンジル基など)、ハロゲン化アラルキル基(たとえば
、4−クロロベンジル基、3−クロロベンジル基、4−
ブロモベンジル基、4−(4−クロロフェニル)ベンジ
ル基など)などがある。Aralkyl groups include =, WIA aralkyl method, for example, benzyl group, phenethyl group, diphenylmethyl group, naphthylmethyl group, etc.; dimethylbenzyl group, 4-isopropylhensyl group, 4-octylbenzyl group, etc.), alkoxyaralkyl group (e.g., 4-methoxybenzyl group,
4-pentafluoropropenyloxybenzyl group, 4-ethoxybenzyl group, etc.), cyanoaralkyl group (e.g. 4-cyanohensyl group, 4-(4-cyanophenyl)
benzyl group, etc.), halogenated aralkyl group (e.g., 4-chlorobenzyl group, 3-chlorobenzyl group, 4-chlorobenzyl group,
bromobenzyl group, 4-(4-chlorophenyl)benzyl group, etc.).
アルキル基の炭素数は1〜12個が好ましく、アラルキ
ル基の炭素数は好ましくは7〜14個である。The alkyl group preferably has 1 to 12 carbon atoms, and the aralkyl group preferably has 7 to 14 carbon atoms.
XはOないし90モル%であり、好ましくは0〜50モ
ル%、yは10ないし99.9モル%であり、好ましく
は10〜95モル%である。X is O to 90 mol%, preferably 0 to 50 mol%, and y is 10 to 99.9 mol%, preferably 10 to 95 mol%.
2は0.1ないし50モル%であり好ましくは1ないし
30モル%である。2 is 0.1 to 50 mol%, preferably 1 to 30 mol%.
Bはエチレン性不飽和基を少なくとも2個有する共重合
可能なモノマーを共重合させた構造単位である。Bの例
はたとえばエチレングリコールジメタクリレート、ジエ
チレングリコールジメタクリレート、ネオペンチルグリ
コールジメタクリレート、テトラメチレングリコールジ
メタクリレート、ペンタエリスリトールテトラメタクリ
レート、トリメチロールプロパントリメタクリレート、
エチレングリコールジアクリレート、ジエチレングリコ
ールジアクリレート、ネオペンチルグリコールジアクリ
レート、テトラメチレングリコールジアクリレート、ト
リメチロールプロパントリアクリレート、アリルメタク
リレート、アリルアクリレート、ジアリルフタレート、
メチレンビスアクリルアシド、メチレンビスメタクリル
アミド、トリビニルシクロヘキサン、ジビニルヘンゼン
、N。B is a structural unit obtained by copolymerizing a copolymerizable monomer having at least two ethylenically unsaturated groups. Examples of B include ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, neopentyl glycol dimethacrylate, tetramethylene glycol dimethacrylate, pentaerythritol tetramethacrylate, trimethylolpropane trimethacrylate,
Ethylene glycol diacrylate, diethylene glycol diacrylate, neopentyl glycol diacrylate, tetramethylene glycol diacrylate, trimethylolpropane triacrylate, allyl methacrylate, allyl acrylate, diallyl phthalate,
Methylenebisacrylic acid, methylenebismethacrylamide, trivinylcyclohexane, divinylhenzene, N.
N−ビス(ビニルベンジル)−N、N−ジメチルアンモ
ニウムクロリド、N、N−ジエチル−N−(メタクリロ
イルオキシエチル)−N−(ビニルヘンシル(アンモニ
ウムクロリド、N、N、N’N1−テトラエチル−N
N’−ビス(ビニルヘンシル(p−キシリレンジアン
モニウムジクロリ1’、NN’−ビス(ビニルベンジル
)−トリエチレンジアンモニウムジクロリド、N、N、
N’N′−テトラブチル−N、N’−ビス(ビニルベン
ジル)−エチレンジアンモニウムジクロリドなどがある
。これらの中でも、疎水性、耐アルカリ性などの点から
、ジビニルヘンゼン、トリビニルシクロヘキサンが特に
好ましい。N-bis(vinylbenzyl)-N,N-dimethylammonium chloride, N,N-diethyl-N-(methacryloyloxyethyl)-N-(vinylhensyl(ammonium chloride, N,N,N'N1-tetraethyl-N
N'-bis(vinylhensyl(p-xylylenediammonium dichloride 1', NN'-bis(vinylbenzyl)-triethylenediammonium dichloride, N, N,
Examples include N'N'-tetrabutyl-N,N'-bis(vinylbenzyl)-ethylenediammonium dichloride. Among these, divinylhenzene and trivinylcyclohexane are particularly preferred from the viewpoint of hydrophobicity, alkali resistance, and the like.
化合物例
Vl−1)
x : y : z=47.5 : 47
.5 : 5■−4)
C11□
(CIICIIt 今−
x:y:z−45:45:10
■−6)
11、C。Compound example Vl-1) x:y:z=47.5:47
.. 5: 5■-4) C11□ (CIICIIt now- x:y:z-45:45:10 ■-6) 11, C.
tHs
y:z=80:20
y:z=95:5
X :y=50:50
これらのポリマーラテックスの好ましい添加量は下塗層
−層につき5〜300mg/n(、好ましくは10〜2
50mg/ポである。tHs y:z=80:20 y:z=95:5
It is 50 mg/po.
次に本発明でカチオン媒染剤と組み合わせて利用できる
好ましい染料について述べる。Next, preferred dyes that can be used in combination with cationic mordants in the present invention will be described.
この様な染料には、例えば英国特許第506385号、
同1,177.429号、同1,311.884号、同
1,338,799号、同1゜385.371号、同1
,467.214号、同1.433,102号、同1,
553,516号、特開昭48−85,130号、同4
9−114゜420号、同52−117.123号、同
55−161.233号、同59−111,640号、
特公昭39−22,069号、同43−13,168号
、米国特許第3.247,127号、同3゜469.9
85号、同4.078,933号等に記載されたピラゾ
ロン核やバルビッール酸核を有するオキソノール染料、
米国特許第2,533゜472号、同3,379,53
3号、英国特許第1.278..621号等記載された
その他のオキソノール染f4、英国特許第575.69
1号、同680.631号、同599.623号、同7
86.907号、同907.125号、同1.O45,
609号、米国特許第4.255,326号、特開昭5
9−211.043号等に記載されたアゾ染料、特開昭
50−100,116号、同54−118,247号、
英国特許第2,014,598号、同750,031号
等に記載されたアゾメチン染料、米国特許第2,865
,752号に記載されたアントラキノン染料、米国特許
第2゜538.009号、同2,688,541号、同
2.538,008号、英国特許第584,609号、
同1,210.252号、特開昭50−40.625号
、同51−3,623号、同51−10.927号、同
54−118,247号、特公昭48−3,286号、
同59−37,303号等に記載されたアゾメチン染料
、特公昭28−3,082号、同44−16,594号
、同59−28,898号等に記載されたスチリル染料
、英国特許第446,583号、同1,335.4■−
6
22号、特開昭59−228,250号等に記載された
トリアリールメタン染料、英国特許筒1゜075.65
3号、同1,153,341号、同1.284,730
号、同1,475,228号、同1,542,807号
等に記載されたメロシアニン染料、米国特許筒2,84
3,486号、同3.294,539号等に記載された
シアニン染料などが挙げられる。Such dyes include, for example, British Patent No. 506385;
1,177.429, 1,311.884, 1,338,799, 1゜385.371, 1
, 467.214, 1.433, 102, 1.
No. 553,516, JP-A-48-85,130, No. 4
9-114゜420, 52-117.123, 55-161.233, 59-111,640,
Japanese Patent Publication No. 39-22,069, No. 43-13,168, U.S. Patent No. 3.247,127, No. 3.469.9
oxonol dyes having a pyrazolone nucleus or barbylic acid nucleus described in No. 85, No. 4.078,933, etc.;
U.S. Patent No. 2,533°472, U.S. Patent No. 3,379,53
No. 3, British Patent No. 1.278. .. Other oxonol dye f4 described in No. 621 etc., British Patent No. 575.69
No. 1, No. 680.631, No. 599.623, No. 7
86.907, 907.125, 1. O45,
No. 609, U.S. Patent No. 4,255,326, JP-A-5
Azo dyes described in JP-A No. 9-211.043, etc., JP-A-50-100,116, JP-A No. 54-118,247,
Azomethine dyes described in British Patent No. 2,014,598, British Patent No. 750,031, etc., U.S. Patent No. 2,865
, 752, U.S. Patent No. 2.538.009, U.S. Pat. No. 2,688,541, U.S. Pat.
1,210.252, JP 50-40.625, JP 51-3,623, JP 51-10.927, JP 54-118,247, JP 48-3,286 ,
Azomethine dyes described in Japanese Patent Publication No. 59-37,303, styryl dyes described in Japanese Patent Publications No. 28-3,082, No. 44-16,594, No. 59-28,898, etc., British Patent No. No. 446,583, 1,335.4■-
Triarylmethane dye described in No. 6 22, JP-A No. 59-228,250, etc., British patent tube 1°075.65
No. 3, No. 1,153,341, No. 1,284,730
No. 1,475,228, No. 1,542,807, etc., U.S. Patent No. 2,84
Examples include cyanine dyes described in No. 3,486 and No. 3,294,539.
代表的な染料を以下に示すが、本発明はこれらに限定さ
れるものではない。Representative dyes are shown below, but the present invention is not limited thereto.
■−3 ■−4 ■−5 ■−2 SO,に 503に ■−9 OJa ■−1 ■−13 ■−14 (C14SO,す (にHzJ 4sU3Na 次に、本発明で用いる乳剤粒子について説明する。■-3 ■-4 ■-5 ■-2 SO, to to 503 ■-9 OJa ■-1 ■-13 ■-14 (C14SO, (HzJ4sU3Na Next, the emulsion grains used in the present invention will be explained.
粒子と同一体積の球相当平均粒子サイズは04μm以上
であることが好ましい。特に0.5〜2.0pmである
ことが好ましい8粒子サイズ分布は狭い方がよい。The sphere-equivalent average particle size of the same volume as the particles is preferably 0.4 μm or more. In particular, the narrower the particle size distribution, which is preferably 0.5 to 2.0 pm, the better.
乳剤中のハロゲン化銀粒子は立方体、八面体のような規
則的(regular)な結晶形を有するものでもよく
、また球状、板状、じゃがいも状などのような変則的(
irregular)な結晶形を有するものでも或いは
これらの結晶形の複合形を有するものでもよい、種々の
結晶形の粒子の混合から成ってもよい、また粒子径が粒
子厚みの5倍以上の平板状粒子は、本発明に対し好まし
く用いられる(詳しくは、RESERRCHDISCL
O3URE225巻Item 22534 P、 2
0〜P、 58.1月号、1983年、及び特開昭58
−127921号、同5B−113926号公報に記載
されている)。The silver halide grains in the emulsion may have a regular crystal shape such as a cube or an octahedron, or may have an irregular crystal shape such as a spherical shape, a plate shape, a potato shape, etc.
It may have an irregular crystal form or a composite form of these crystal forms, it may consist of a mixture of particles of various crystal forms, and it may have a tabular shape with a particle diameter of 5 times or more the particle thickness. Particles are preferably used for the present invention (in particular, RESERRCHDISCL
O3URE Volume 225 Item 22534 P, 2
0-P, 58. January issue, 1983, and Japanese Patent Application Publication No. 1983
-127921 and 5B-113926).
平板状ハロゲン化銀粒子の製法としては、当業界で知ら
れた方法を適宜、組合せることにより成し得る。The tabular silver halide grains can be produced by appropriately combining methods known in the art.
平板状ハロゲン化銀乳剤は、フナツク(Cugnac)
およびシャ) (Chateau ) r物理的熟
成時の臭化銀結晶の形態学の進展(イボルージョン・オ
ブ・ザ・モルフオルジー・オブ・シルバー・ブロマイド
・クリスタルズ・デエアリング・フィジカル・ライブニ
ング)」サイエンス・工・インダストリエ・フォトグラ
フィー、33巻、N11(1962)、pp、121−
125、ダフィン(Duffin )著[フォトグラフ
ィク・エマルシヨン・ケミストリ′−(Photogr
aphic emulsion Chea+1stry
) Jフォーカル・プレス(Focal Press
) 、ニューヨーク、1966年、p−66〜p、72
、A、 P、 H。The tabular silver halide emulsion is manufactured by Cugnac.
and Chateau) ``Evolution of the Morphology of Silver Bromide Crystals During Physical Ripening'' Science. Industrial Photography, Volume 33, N11 (1962), pp, 121-
125, Duffin [Photographic Emulsion Chemistry'-(Photogr.
aphic emulsion Chea+1try
) J Focal Press
), New York, 1966, p-66-p, 72
, A, P, H.
トリベリ(Trivell+) 、W、 F、 ス
ミス(Sm1th )フォトグラフィク ジャーナル(
PhotographicJournal ) 、80
巻、285頁(1940年)等に記載されているが特開
昭58−127,921、特開昭58−113,927
、特開昭58−113.928、米国特許第44395
20号に記載された方法を参照すれば容易に調製できる
。Trivell+, W, F. Smith Photographic Journal (
Photographic Journal), 80
Volume, page 285 (1940), etc., but JP-A-58-127,921 and JP-A-58-113,927.
, JP 58-113.928, U.S. Patent No. 44395
It can be easily prepared by referring to the method described in No. 20.
本発明の効果を有効に利用するためには、乳剤固装工程
中の化学増感の際に、ハロゲン化銀1モルあたり300
■以上のハロゲン化銀吸着性物質を存在させることが好
ましい。このハロゲン化銀吸着性物質は、粒子形成中、
粒子形成直後、後熟開始前後熟時などいずれの時期に添
加してもよいが化学増感剤(例えば、金や硫黄増感剤)
の添加されるより前、もしくは化学増感剤と同時に添加
されることが好ましく、少なくとも、化学増感が進行す
る過程で、存在している必要がある。In order to effectively utilize the effects of the present invention, it is necessary to apply a
(2) It is preferable that the above silver halide adsorbing substance be present. This silver halide adsorptive substance is used during grain formation.
Chemical sensitizers (e.g., gold or sulfur sensitizers) may be added at any time, such as immediately after grain formation, before or after ripening begins, or during ripening.
It is preferable to add the sensitizer before the chemical sensitizer is added or at the same time as the chemical sensitizer, and it must be present at least during the process of chemical sensitization.
ハロゲン化銀吸着性物質の添加条件として、温度は30
°C〜80°Cの任意の温度でよいが、吸着性を強化す
る目的で、50゛C〜80°Cの範囲が好ましい、PH
,PAgも任意でよいが、化学増感をおこなう時点では
pH6〜10.pAg7〜9であることが好ましい。As a condition for adding the silver halide adsorbent substance, the temperature is 30°C.
PH
, PAg may be optional, but at the time of chemical sensitization, the pH is 6 to 10. It is preferable that pAg is 7-9.
本発明でいう、ハロゲン化銀吸着性物質とは増悪色素、
もしくは写真性能安定化剤の類を意味する。In the present invention, the silver halide adsorbing substances are aggravating dyes,
Or it means a type of photographic performance stabilizer.
すなわちアゾール類(例えばベンゾチアゾリウム塩、ペ
ンゾイミダゾウム塩、イミダゾール類、ベンズイミダゾ
ール類、ニトロインダゾール類、トリアゾール類、ベン
ゾトリアゾール類、テトラゾール類、トリアジン類など
) ;メルカプト化合物[(例えばメルカプトチアゾー
ル類、メルカプトベンゾチアゾール類、メルカプトイミ
ダゾール類、メルカプトベンズイミダゾール類、メルカ
プトベンゾオキサゾール類、メルカプトチアジアゾール
類、メルカプトオキサジアゾール類、メルカプトテトラ
ゾール類、メルカプトトリアゾール類、メルカプトピリ
ミジン類、メルカプトトリアジン類など1 ;例えばオ
キサドリンチオンのようなチオケト化合物;アザインデ
ン類(例えばトリアザインデン類、テトラアザインデン
類(特に4−ヒドロキシ置換(1,3,3a、7)テト
ラアザインデン類)、ペンタアザインデン類など);の
ようなカブリ防止剤または安定剤として知られた、多く
の化合物をハロゲン化銀吸着物質としてあげることがで
きる。Namely, azoles (e.g. benzothiazolium salts, penzimidazome salts, imidazoles, benzimidazoles, nitroindazoles, triazoles, benzotriazoles, tetrazoles, triazines, etc.); mercapto compounds [(e.g. mercaptothiazole) mercaptobenzothiazoles, mercaptoimidazoles, mercaptobenzimidazoles, mercaptobenzoxazoles, mercaptothiadiazoles, mercaptooxadiazoles, mercaptotetrazoles, mercaptotriazoles, mercaptopyrimidines, mercaptotriazines, etc.1; e.g. Thioketo compounds such as oxadorinthione; azaindenes (e.g. triazaindenes, tetraazaindenes (especially 4-hydroxy-substituted (1,3,3a,7) tetraazaindenes), pentaazaindenes, etc.); A number of compounds known as antifoggants or stabilizers can be mentioned as silver halide adsorbents.
さらに、プリン類または核酸類、あるいは特公昭61−
36213号、特開昭59−90844号、等に記載の
高分子化合物、なども利用しうる吸着性物質である。Furthermore, purines or nucleic acids, or
36213, JP-A No. 59-90844, and the like are also usable adsorbent substances.
なかでも特にアザインデン類とプリン類、核酸類は本発
明に好ましく、用いることができる。これらの化合物の
添加量はハロゲン化銀1モルあたり300〜3000■
、好ましくは、500〜2500mgである。Among them, azaindenes, purines, and nucleic acids are particularly preferred and can be used in the present invention. The amount of these compounds added is 300 to 3000 cm per mole of silver halide.
, preferably 500 to 2500 mg.
本発明のハロゲン化銀吸着性物質として、増感色素は、
好ましい効果を実現しうる。As the silver halide adsorbing substance of the present invention, the sensitizing dye is
A desirable effect can be achieved.
増感色素として、シアニン色素、メロシアニン色素、コ
ンプレックスシアニン色素、コンプレックスメロシアニ
ン色素、ホロホーラージアニン色素、スチリル色素、ヘ
ミシアニン色素、オキソノール色素、ヘミオキソノール
色素等を用いることができる。As the sensitizing dye, cyanine dyes, merocyanine dyes, complex cyanine dyes, complex merocyanine dyes, holopholarianine dyes, styryl dyes, hemicyanine dyes, oxonol dyes, hemioxonol dyes, etc. can be used.
本発明に使用される有用な増悪色素は例えば米国特許3
,522,052号、同3,619,197号、同3,
713,828号、同3,615゜643号、同3,6
15,632号、同3.617.293号、同3,62
8,964号、同3゜703.377号、同3,666
.480号、同3.667.960号、同3,679,
428号、同3,672,897号、同3,769.0
26号、同3,556.800号、同3,615,61
3号、同3,615,638号、同3,615゜635
号、同3,705.809号、同3,632.349号
、同3,677.765号、同3゜770.449号、
同3,770,440号、同3.769,025号、同
3,745,014号、同3,713,828号、同3
,567.458号、同3,625,698号、同2,
526,632号、同2,503.776号、特開昭4
8=76525号、ベルギー特許第691,807号な
どに記載されている。増感色素の添加量はハロゲン化1
11モルあたり300■以上20001g未満、好まし
くは500■以上1000■未満がよい。Useful enhancing dyes for use in the present invention include, for example, U.S. Pat.
, No. 522,052, No. 3,619,197, No. 3,
No. 713,828, No. 3,615゜643, No. 3,6
No. 15,632, No. 3.617.293, No. 3,62
No. 8,964, No. 3703.377, No. 3,666
.. No. 480, No. 3.667.960, No. 3,679,
No. 428, No. 3,672,897, No. 3,769.0
No. 26, No. 3,556.800, No. 3,615,61
No. 3, No. 3,615,638, No. 3,615゜635
No. 3,705.809, No. 3,632.349, No. 3,677.765, No. 3770.449,
No. 3,770,440, No. 3,769,025, No. 3,745,014, No. 3,713,828, No. 3
, No. 567.458, No. 3,625,698, No. 2,
No. 526,632, No. 2,503.776, JP-A-4
8=76525, Belgian Patent No. 691,807, etc. The amount of sensitizing dye added is halogenated 1
It is preferably 300 to less than 20,001 g, preferably 500 to less than 1,000 g per 11 moles.
以下に本発明で有効な増感色素の具体例を示す。Specific examples of sensitizing dyes useful in the present invention are shown below.
C,Hs SO+に 5O1− 3O,K O3K 以上の中で特にシアニン色素が好ましい。C, Hs to SO+ 5O1- 3O,K O3K Among the above, cyanine dyes are particularly preferred.
増感色素と前述の安定化剤を併用することは好ましい態
様である。A preferred embodiment is to use the sensitizing dye and the above-mentioned stabilizer together.
本発明に用いる増感色素は化学増感後塗布までの間に添
加しても良い。The sensitizing dye used in the present invention may be added after chemical sensitization and before coating.
本発明の平板状乳剤の投影面積直径は0.3〜2.0a
m、特に0.5〜1.2pmであることが好ましい、ま
た平行平面間距離(粒子の厚み)としては0.05μm
〜0.3μm、特に0. 1〜0.25μmのものが好
ましく、アスペクト比としては、3以上、20未満、特
に4以上8未満のものが好ましい0本発明の平板状ハロ
ゲン化銀乳剤中には、アスペクト比が2以上のハロゲン
化銀粒子が全粒子の50%(投影面積)以上、特に70
%以上存在し、その平板粒子の平均アスペクト比が3以
上、特に4〜Bであることが好ましい
平板状ハロゲン化銀粒子の中でも単分散六角平板粒子は
とりわけ有用な粒子である。The projected area diameter of the tabular emulsion of the present invention is 0.3 to 2.0a.
m, preferably 0.5 to 1.2 pm, and the distance between parallel planes (particle thickness) is 0.05 μm
~0.3 μm, especially 0.3 μm. The silver halide emulsion of the present invention preferably has an aspect ratio of 1 to 0.25 μm, and the aspect ratio is preferably 3 or more and less than 20, particularly 4 or more and less than 8. Silver halide grains account for more than 50% (projected area) of all grains, especially 70%
Among the tabular silver halide grains, which preferably have an average aspect ratio of 3 or more, particularly 4 to B, monodisperse hexagonal tabular grains are particularly useful grains.
本発明でいう単分散六角平板粒子の構造および製造法の
詳細は特願昭61−299155の記載に従う。The structure and manufacturing method of the monodisperse hexagonal tabular grains referred to in the present invention are as described in Japanese Patent Application No. 61-299155.
本発明に用いられるハロゲン化銀乳剤の化学増感の方法
としては前述のハロゲン化銀吸着性物質の存在下で硫黄
増感法、セレン増感法、還元増感法、金増感法などの知
られている方法を用いることができ、単独または組合せ
て用いられる。Methods for chemically sensitizing the silver halide emulsion used in the present invention include sulfur sensitization, selenium sensitization, reduction sensitization, gold sensitization, etc. in the presence of the silver halide adsorbing substance described above. Known methods can be used, used alone or in combination.
貴金属増感法のうち金増感法はその代表的なもので金化
合物、主として全錯塩を用いる。全以外の貴金属、たと
えば白金、パラジウム、イリジウム等の錯塩を含有して
も差支えない、その具体例は米国特許2,448.06
0号、英国特許618.061号などに記載されている
。Among the noble metal sensitization methods, the gold sensitization method is a typical method and uses a gold compound, mainly a total complex salt. It may contain complex salts of noble metals other than pure metals, such as platinum, palladium, iridium, etc., a specific example of which is disclosed in U.S. Patent No. 2,448.06.
No. 0, British Patent No. 618.061, etc.
硫黄増感剤としては、ゼラチン中に含まれる硫黄化合物
のほか、種々の硫黄化合物、たとえばチオ硫酸塩、チオ
尿素類、チアゾール類、ローダニン類等を用いることが
できる。具体例は米国特許1.574,944号、同2
,278.947号、同2,410,689号、同2,
728,668号、同3,501,313号、同3.6
56.955号に記載されたものである。As the sulfur sensitizer, in addition to the sulfur compounds contained in gelatin, various sulfur compounds such as thiosulfates, thioureas, thiazoles, rhodanines, etc. can be used. Specific examples are U.S. Patent Nos. 1,574,944 and 2.
, No. 278.947, No. 2,410,689, No. 2,
No. 728,668, No. 3,501,313, No. 3.6
56.955.
チオ硫酸塩による硫黄増感と、金増感の併用は本発明の
効果を存効に発揮しうる。The combined use of sulfur sensitization using thiosulfate and gold sensitization can effectively exhibit the effects of the present invention.
還元増感剤としては第一すず塩、アミン類、ホルムアミ
ジンスルフィン酸、シラン化合物などを用いることがで
きる。As the reduction sensitizer, stannous salts, amines, formamidine sulfinic acid, silane compounds, etc. can be used.
本発明に用いられる写真乳剤には、感光材料の製造工程
、保存中あるいは写真処理中のカプリを防止し、あるい
は写真性能を安定化させる目的で、本発明の化学増感工
程でのハロゲン化銀吸着性物質とは別に種々の化合物を
含存させることができる。すなわちアゾール類(例えば
ベンゾチアゾリウム塩、ニトロイミダゾール類、ニトロ
ベンズイミダゾール類、クロロベンズイミダゾール類、
ブロモベンズイミダゾール類、ニトロインダゾール類、
ベンゾトリアゾール類、アミノトリアゾール類など)
;メルカプト化合物類(例えばメルカプトチアゾール類
、メルカプトベンゾチアゾール類、メルカプトベンズイ
ミダゾール類、メルカプトチアジアゾール類1、メルカ
プトテトラゾール類、メルカプトピリミジン類、メルカ
プトトリアジン類など) ;例えばオキサドリンチオン
のようなチオケト化合物;アザインデン類(例えばトリ
アザインデン類、テトラアザインデン類(特に4−ヒド
ロキシ置換(1,3,3a、7)テトラアザインデン類
)、ペンタアザインデン類など) ;ベンゼンチオスル
ホン酸、ベンゼンスルフィン酸、ベンゼンスルホ酸アミ
ド等のようなカブリ防止剤または安定剤として知られた
、多くの化合物を加えることができる。The photographic emulsion used in the present invention contains silver halide in the chemical sensitization process of the present invention for the purpose of preventing capri during the manufacturing process, storage, or photographic processing of light-sensitive materials, or stabilizing photographic performance. Various compounds can be included in addition to the adsorptive substance. That is, azoles (e.g. benzothiazolium salts, nitroimidazoles, nitrobenzimidazoles, chlorobenzimidazoles,
Bromobenzimidazoles, nitroindazoles,
benzotriazoles, aminotriazoles, etc.)
; Mercapto compounds (e.g. mercaptothiazoles, mercaptobenzothiazoles, mercaptobenzimidazoles, mercaptothiadiazoles 1, mercaptotetrazoles, mercaptopyrimidines, mercaptotriazines, etc.) ; Thioketo compounds such as oxadorinthione; azaindene (e.g. triazaindenes, tetraazaindenes (especially 4-hydroxy-substituted (1,3,3a,7) tetraazaindenes), pentaazaindenes, etc.); benzenethiosulfonic acid, benzenesulfinic acid, benzene Many compounds known as antifoggants or stabilizers can be added, such as sulfonic acid amides and the like.
特に特開昭60−76743号、同60−87322号
公報に記載のニトロン及びその誘導体、特開昭60−8
0839号公報に記載のメルカプト化合物、特開昭57
−164735号公報に記載のへテロ環化合物、及びヘ
テロ環化合物と銀の錯塩(例えば1−フェニル−5−メ
ルカプトテトラゾール11)などを好ましく用いること
ができる。In particular, nitrone and its derivatives described in JP-A-60-76743 and JP-A-60-87322, JP-A-60-8
Mercapto compound described in Publication No. 0839, JP-A-57
The heterocyclic compound described in JP-A-164735 and a complex salt of a heterocyclic compound and silver (for example, 1-phenyl-5-mercaptotetrazole 11) can be preferably used.
化学増感工程でハロゲン化銀吸着性物質として増感色素
を用いた場合でも必要に応じて、他の波長域の分光増感
色素を添加してもよい。Even when a sensitizing dye is used as a silver halide adsorbing substance in the chemical sensitization step, spectral sensitizing dyes in other wavelength ranges may be added as necessary.
本発明を用いて作られる感光材料の写真乳剤層または他
の親水性コロイド層には塗布助剤、帯電防止、スベリ性
改良、乳化分散、接直防止及び写真特性改良(例えば、
現像促進、硬膜剤、増感)等積々の目的で、種々の界面
活性剤を含んでもよい。The photographic emulsion layer or other hydrophilic colloid layer of the light-sensitive material prepared using the present invention may contain coating aids, antistatic properties, smoothness improvement, emulsification dispersion, direct prevention, and improvement of photographic properties (e.g.
Various surfactants may be included for various purposes such as development acceleration, hardening agent, sensitization, etc.
例えばサポニン(ステロイド系)、アルキレンオキサイ
ド誘導体(例えばポリエチレングリコール、ポリエチレ
ングリコール/ポリプロピレングリコール縮合物、ポリ
エチレングリコールアルキルエーテル類又はポリエチレ
ングリコールアルキルアリールエーテル類、シリコーン
のポリエチレンオキサイド付加物類)、糖のアルキルエ
ステル類などの非イオン性界面活性剤;
アルキルスルフォン酸塩、アルキルベンゼンスルフォン
酸塩、アルキルナフタレンスルフォン酸塩、アルキル硫
酸エステル類、
N−アシル−N−アルキルタウリン類、スルホコハク酸
エステル類、スルホアルキルポリオキシエチレンアルキ
ルフェニルエーテル類、などのアニオン界面活性剤;
アルキルベタイン類、アルキルスルホベタイン類などの
両性界面活性剤;
脂肪族あるいは芳香族第4級アンモニウム塩類、ピリジ
ニウム塩類、イミダゾリウム塩類などのカチオン界面活
性剤を用いることができる。For example, saponins (steroids), alkylene oxide derivatives (e.g. polyethylene glycol, polyethylene glycol/polypropylene glycol condensates, polyethylene glycol alkyl ethers or polyethylene glycol alkylaryl ethers, polyethylene oxide adducts of silicones), alkyl esters of sugars. Nonionic surfactants such as; alkyl sulfonates, alkylbenzene sulfonates, alkylnaphthalene sulfonates, alkyl sulfates, N-acyl-N-alkyl taurines, sulfosuccinates, sulfoalkyl polyoxyethylenes Anionic surfactants such as alkylphenyl ethers; Ampholytic surfactants such as alkylbetaines and alkylsulfobetaines; Cationic surfactants such as aliphatic or aromatic quaternary ammonium salts, pyridinium salts, imidazolium salts can be used.
この内、サポニン、ドデシルベンゼンスルホン酸Na塩
、ジー2−工tルヘキシルα−スルホコハク酸N、a塩
、p−オクチルフエノキシエトキシエクンスルホン酸N
a塩、ドデシル硫@Na塩、トリイソプロピルナフタレ
ンスルホン酸Na塩、N−メチル−オレオイルタウリン
Na塩、等のアニオン、ドデシルトリメチルアンモニウ
ムクロライド、N−オレオイル−N’、N’、N’−1
−リメチルアンモニオジアミノプロバンブロマイド、ド
デシルピリジウムクロライドなどのカチオン、N−ドデ
シル−N、N−ジメチルカルボキシベタイン、N−オレ
イル−N、N−ジメチルスルホブチルベタインなどのベ
タイン、ポリ(平均重合度n−10)尤キシエチレンセ
チルエーテル、ポリ(n=25)オキシエチレンp−ノ
ニルフェノールエーテル、ビス〔1−ポリ(n−15)
オキシエチレン−オキシ−2,4−ジーも一ペンチルフ
ェニル)エタンなどのノニオンを特に好ましく用いるこ
とができる。Among these, saponin, dodecylbenzenesulfonic acid Na salt, di-2-ethylhexyl α-sulfosuccinic acid N, a salt, p-octylphenoxyethoxyechnesulfonic acid N
anions such as a salt, dodecyl sulfur @ Na salt, triisopropylnaphthalene sulfonic acid Na salt, N-methyl-oleoyl taurine Na salt, dodecyltrimethylammonium chloride, N-oleoyl-N', N', N'- 1
- Cations such as limethylammoniodiaminoprobane bromide and dodecylpyridium chloride, betaines such as N-dodecyl-N, N-dimethylcarboxybetaine, N-oleyl-N, and N-dimethylsulfobutylbetaine, poly(average degree of polymerization) n-10) oxyethylene cetyl ether, poly(n=25) oxyethylene p-nonylphenol ether, bis[1-poly(n-15)
Nonions such as oxyethylene-oxy-2,4-(pentylphenyl)ethane can be particularly preferably used.
帯電防止剤としてはパーフルオロオクタンスルホニルに
塩、N−プロピル−N−パーフルオロオクタンスルホニ
ルグリシンNa塩、N−プロピル−N−パーフルオロオ
クタンスルホニルアミノエチルオキシポリ(n−3)オ
キシエチレンブタンスルホン酸Na塩、N−パーフルオ
ロオクタンスルホニル−N’、N’、N’−1−リメチ
ルアンモニオジアミノブロパンクロライド、N−パーフ
ルオロデカノイルアミノプロピル−N’、N’−ジメチ
ル−N’−カルボキシベタインの如き含フツ素界面活性
剤、特開昭60−80848号、同61−112144
号、特願昭61〜13398号、同61−16056号
などに記載のノニオン系界面活性剤、アルカリ金属の硝
酸塩、導電性酸化スズ、酸化亜鉛、五酸化バナジウム又
はこれらにアンチモン等をドープした複合酸化物を好ま
しく用いることができる。As antistatic agents, perfluorooctanesulfonyl salt, N-propyl-N-perfluorooctanesulfonylglycine Na salt, N-propyl-N-perfluorooctanesulfonylaminoethyloxypoly(n-3)oxyethylenebutanesulfonic acid Na salt, N-perfluorooctanesulfonyl-N', N', N'-1-limethylammoniodiaminopropane chloride, N-perfluorodecanoylaminopropyl-N', N'-dimethyl-N'- Fluorine-containing surfactants such as carboxybetaine, JP-A-60-80848, JP-A-61-112144
Nonionic surfactants, alkali metal nitrates, conductive tin oxide, zinc oxide, vanadium pentoxide, or composites of these doped with antimony, etc. Oxides can be preferably used.
本発明に於てはマット剤として米国特許第299210
1号、同2701245号、同4142894号、同4
396706号に記載の如きポリメチルメタクリレート
のホモポリマー又はメチルメタクリレートとメタクリル
酸とのコポリマーデンプンなどの有機化合物、シリカ、
二酸化チタン、硫酸、ストロンチウムバリウム等の無機
化合物の微粒子を用いることができる。In the present invention, U.S. Patent No. 299210 is used as a matting agent.
No. 1, No. 2701245, No. 4142894, No. 4
Homopolymers of polymethyl methacrylate or copolymers of methyl methacrylate and methacrylic acid as described in No. 396,706, organic compounds such as starch, silica,
Fine particles of inorganic compounds such as titanium dioxide, sulfuric acid, strontium barium, etc. can be used.
粒子サイズとしては1.0〜lOμm、特に2〜5μm
であることが好ましい。The particle size is 1.0 to 10 μm, especially 2 to 5 μm.
It is preferable that
本発明の写真感光材料の表面層には、滑り剤として米国
特許第3489576号、同4047958号等に記載
のシリコーン化合物、特公昭56−23139号公報に
記載のコロイダルシリカの他に、パラフィンワックス、
高級脂肪酸エステル、デン粉誘導体等を用いることがで
きる。In the surface layer of the photographic material of the present invention, in addition to the silicone compounds described in U.S. Pat.
Higher fatty acid esters, starch derivatives, etc. can be used.
本発明の写真感光材料の親水性コロイド層には、トリメ
チロールプロパン、ベンタンジオール、ブタンジオール
、エチレングリコール、グリセリン等のポリオール類を
可塑剤として用いることができる。Polyols such as trimethylolpropane, bentanediol, butanediol, ethylene glycol, and glycerin can be used as plasticizers in the hydrophilic colloid layer of the photographic material of the present invention.
本発明の感光材料の乳剤層や中間層および表面保護層に
用いることのできる結合剤または保護コロイドとしては
、ゼラチンをもちいるのが有利であるが、それ以外の親
水性コロイドも用いることができる。As the binder or protective colloid that can be used in the emulsion layer, intermediate layer, and surface protective layer of the light-sensitive material of the present invention, it is advantageous to use gelatin, but other hydrophilic colloids can also be used. .
例えばゼラチン誘導体、ゼラチンと他の高分子とのグラ
フトポリマー、アルブミン、カゼイン等の蛋白質:ヒド
ロキシエチルセルロース、カルボキシメチルセルロース
、セルロース硫酸エステル類等の如きセルロース誘導体
、アルギン酸ソーダ、デキストラン、澱粉誘導体などの
WI誘導体;ポリビニルアルコール、ポリビニルアルコ
ール部分アセタール、ポリ−N−ビニルピロリドン、ポ
リアクリル酸、ポリメタクリル酸、ポリアクリルアミド
、ポリビニルイミダゾール、ポリビニルピラゾール等の
単一あるいは共重合体の如き多種の合成親水性高分子物
質を用いることができる。For example, gelatin derivatives, graft polymers of gelatin and other polymers, proteins such as albumin and casein; cellulose derivatives such as hydroxyethyl cellulose, carboxymethyl cellulose, and cellulose sulfate esters; WI derivatives such as sodium alginate, dextran, and starch derivatives; Various synthetic hydrophilic polymeric substances such as single or copolymers of polyvinyl alcohol, polyvinyl alcohol partial acetal, poly-N-vinylpyrrolidone, polyacrylic acid, polymethacrylic acid, polyacrylamide, polyvinylimidazole, polyvinylpyrazole, etc. Can be used.
ゼラチンとしては石灰処理ゼラチンのほか、酸処理ゼラ
チンや酵素処理ゼラチンを用いてもよ(、また、ゼラチ
ンの加水分解物や酵素分解物も用いることができる。As the gelatin, in addition to lime-treated gelatin, acid-treated gelatin or enzyme-treated gelatin may be used (also, gelatin hydrolysates or enzymatically decomposed products can also be used).
これらの中でもゼラチンとともに平均分子量5万以下の
デキストランやポリアクリルアミドを併用することが好
ましい、特願昭61−213503、同じ<61−29
8405に記載の方法は本発明でも有効である。Among these, it is preferable to use dextran or polyacrylamide with an average molecular weight of 50,000 or less together with gelatin.
The method described in No. 8405 is also effective in the present invention.
本発明の写真乳剤及び非感光性の親水性コロイドには無
機または有機の硬膜剤を含有してよい。The photographic emulsions and non-photosensitive hydrophilic colloids of the present invention may contain inorganic or organic hardeners.
例えばクロム塩(クロム明ばん、酢酸クロムなど)、ア
ルデヒド類(ホルムアルデヒド、グリオキサール、グリ
タールアルデヒドなど)、N−メチロール化合物(ジメ
チロール尿素、メチロールジメチルヒダントインなど)
、ジオキサン誘導体(2゜3−ジヒドロキシジオキサン
など)、活性ビニル化合物(1,3,5−)リアクリロ
イル−へキサヒトローS−)リアジン、ビス(ビニルス
ルホニル)メチルエーテル、N、N’−メチレンビス〔
β−(ビニルスルホニル)プロピオンアミド〕など)、
活性ハロゲン化合物(2,4−ジクロル−6−ヒドロキ
シ−5−t−リアジンなど)、ムコハロゲン酸IW(ム
コクロル酸、ムコフェノキシクロル酸など)イソオキサ
ゾール類、ジアルデヒドでん粉、2−クロル−6−ヒド
ロキシトリアジニル化ゼラチンなどを、単独または組合
せて用いることができる。なかでも、特開昭53−41
2211同53−57257、同59−162546、
同60−80846に記載の活性ビニル化合物および米
国特許3,325,287号に記載の活性ハロゲン化物
が好ましい。For example, chromium salts (chromium alum, chromium acetate, etc.), aldehydes (formaldehyde, glyoxal, glitaraldehyde, etc.), N-methylol compounds (dimethylol urea, methylol dimethylhydantoin, etc.)
, dioxane derivatives (2゜3-dihydroxydioxane, etc.), active vinyl compounds (1,3,5-)lyacryloyl-hexahytrose-) riazine, bis(vinylsulfonyl)methyl ether, N,N'-methylenebis[
β-(vinylsulfonyl)propionamide], etc.),
Active halogen compounds (2,4-dichloro-6-hydroxy-5-t-riazine, etc.), mucohalogen acid IW (mucochloric acid, mucophenoxychloroic acid, etc.) isoxazoles, dialdehyde starch, 2-chloro-6- Hydroxytriazinylated gelatin and the like can be used alone or in combination. Among them, JP-A-53-41
2211 53-57257, 59-162546,
The active vinyl compounds described in US Pat. No. 60-80846 and the active halides described in US Pat. No. 3,325,287 are preferred.
本発明の硬膜剤として、高分子硬膜剤も有効に利用しう
る。Polymer hardeners can also be effectively used as hardeners in the present invention.
本発明に用いられる高分硬膜剤としては例えばジアルデ
ヒド澱粉、ポリアクロレイン、米国特許3.396.0
29号記載のアクロレイン共重合体のようなアルデヒド
基を有するポリマー、米国特許第3,623.878号
記載のエポキシ基を有するポリマー、米国特許第3,3
62,827号、リサーチ・ディスクロージャー誌17
333(1978)などに記載されているジクロロトリ
アジン基を有するポリマー、特開昭56−66841に
記載されている活性エステル基を有するポ・リマー、特
開昭56−142524、米国特許第4.161,40
7号、特開昭54−65033、リサーチ・ディスクロ
ージャー誌16725 (1978)などに記載されて
いる活性ビニル基、あるいはその前駆体となる基を有す
るポリマーなどが挙げられ、活性ビニル基、あるいはそ
の前駆体となる基を有するポリマーが好ましく、中でも
特開昭56−142524に記載されている様な、長い
スペーサーによって活性ビニル基、あるいはその前駆体
となる基がポリマー主鎖に結合されているようなポリマ
ーが特に好ましい。Examples of the polymeric hardening agent used in the present invention include dialdehyde starch, polyacrolein, and U.S. Patent No. 3.396.0.
Polymers having aldehyde groups such as acrolein copolymers described in US Pat. No. 3,623.878, polymers having epoxy groups as described in US Pat.
No. 62,827, Research Disclosure Magazine 17
333 (1978), polymers having active ester groups as described in JP-A-56-66841, JP-A-56-142524, U.S. Patent No. 4.161. ,40
No. 7, JP-A-54-65033, Research Disclosure Magazine 16725 (1978), etc., polymers having an active vinyl group or a group that is a precursor thereof, etc. Preferred are polymers having a group that serves as an active vinyl group, or a group that serves as a precursor thereof, bonded to the polymer main chain by a long spacer as described in JP-A-56-142524. Polymers are particularly preferred.
好ましくは、XはOないし75、yは25ないし100
の値をとる。Preferably, X is O to 75 and y is 25 to 100
takes the value of
本発明の写真感光材料中の親水性コロイド層はこれらの
硬膜剤により水中での膨潤率が300%以下、特に20
0〜270%になるように硬膜されていることが好まし
い。The hydrophilic colloid layer in the photographic light-sensitive material of the present invention has a swelling rate of 300% or less in water, especially 20% by the use of these hardening agents.
It is preferable that the film be hardened to 0 to 270%.
支持体としてはポリエチレンテレフタレートフィルムま
たは三酢酸セルロースフィルムが好ましい。As the support, polyethylene terephthalate film or cellulose triacetate film is preferred.
支持体は親水性コロイド層との密着力を向上せしめるた
めに、その表面をコロナ放電処理、あるいはクロー放電
処理あるいは紫外線照射処理する方法が好しくあるいは
、スチレンブタジェン系ラテックス、塩化ビニリデン系
ラテックス等からなる下塗層を設けてもよくまた、その
上層にゼラチン層を更に設けてもよい。In order to improve the adhesion with the hydrophilic colloid layer, the surface of the support is preferably subjected to corona discharge treatment, claw discharge treatment, or ultraviolet irradiation treatment, or styrene-butadiene-based latex, vinylidene chloride-based latex, etc. An undercoat layer may be provided, and a gelatin layer may be further provided on top of the undercoat layer.
またポリエチレン膨潤剤とゼラチンを含む有機溶剤を用
いた下塗層を設けてもよい、これ等の下塗層は表面処理
を加えることで更に親水性コロイド層との密着力を向上
することもできる。In addition, an undercoat layer may be provided using an organic solvent containing a polyethylene swelling agent and gelatin.These undercoat layers can be surface-treated to further improve their adhesion to the hydrophilic colloid layer. .
本発明の写真感光材料の乳剤層には圧力特性を改良する
ためポリマーや乳化物などの可塑剤を含有させることが
できる。The emulsion layer of the photographic material of the present invention may contain a plasticizer such as a polymer or an emulsion in order to improve pressure characteristics.
たとえば英国特許第738,618号には異部環状化合
物を同738,637号にはアルキルフタレートを、同
738,639号にはアルキルエステルを、米国特許第
2,960.404号には多価アルコールを、同3,1
21,060号にはカルボキシアルキルセルロースを、
特開昭495017号にはパラフィンとカルボン酸塩を
、特公昭53−28086号にはアルキルアクリレート
と有機酸を用いる方法等が開示されている。For example, British Patent No. 738,618 describes heterocyclic compounds, British Patent No. 738,637 describes alkyl phthalates, British Patent No. 738,639 describes alkyl esters, and U.S. Patent No. 2,960.404 describes polyhydric compounds. Alcohol, 3.1
No. 21,060 contains carboxyalkyl cellulose,
Japanese Patent Application Laid-open No. 495017 discloses a method using paraffin and a carboxylic acid salt, and Japanese Patent Publication No. 53-28086 discloses a method using an alkyl acrylate and an organic acid.
本発明のハロゲン化銀写真感光材料の乳剤層のその他の
構成については特に制限はなく、必要に応じて種々の添
加剤を用いることができる。例えば、Re5earch
Disclosurs 176巻22〜28頁(1
978年12月)に記載されたバインダー界面活性剤、
その他染料、紫゛外線吸収剤、塗布助剤、増粘剤、など
を用いることができる。There are no particular restrictions on other structures of the emulsion layer of the silver halide photographic material of the present invention, and various additives may be used as required. For example, Re5search
Disclosurs, Vol. 176, pp. 22-28 (1
Binder surfactant described in December 978),
Other dyes, ultraviolet absorbers, coating aids, thickeners, etc. can also be used.
以下、実施例にて本発明を具体的に説明する。Hereinafter, the present invention will be specifically explained with reference to Examples.
実施例1
1■二巨袈
水1ffi中に臭化カリ5g、沃化カリ0.05g、ゼ
ラチン25.0g、チオエーテル
HO(CHI)、 S (CHz)z S (CH,)
20Hの5%水溶液2.5ccを添加し69°Cに保っ
た溶液中へ、撹拌しながら硝酸銀8.33gの水溶液と
、臭化カリ5.94g、沃化カリO,726gを含む水
溶液とをダブルジェット法により45秒間で添加した。Example 1 1 ■ 5g of potassium bromide, 0.05g of potassium iodide, 25.0g of gelatin, thioether HO (CHI), S (CHz)z S (CH,) in 1ffi of 2-kyokan water
2.5 cc of a 5% aqueous solution of 20H was added and kept at 69°C, and an aqueous solution of 8.33 g of silver nitrate and an aqueous solution containing 5.94 g of potassium bromide and 726 g of potassium iodide O were added with stirring. It was added in 45 seconds using the double jet method.
続いて臭化カリ2.5gを添加したのち、硝酸銀8.3
3gを含む水溶液を26分かけて、添加終了時の流量が
添加開始時の2倍となるように添加した。このあと25
%のアンモニア溶液20cc、50%N Ha N 0
3 10 ccを添加して20分間物理熟成したのちI
Nの硫酸240ccを添加して中和し、引き続いて硝酸
11153.34gの水溶液と臭化カリの水溶液を、電
位をp、Ag8.2に保ちながらコントロールダブルジ
ェット法で40分間で添加した。この時の流量は添加終
了時の流量が、添加開始時の流量の9倍となるよう加速
した。W5加終了後2Nのチオシアン酸カリウム溶液1
5ccを添加し、さらに1%の沃化カリ水溶液25cc
を30秒かけて添加した。このあと温度を35°Cに下
げ、沈降法により可溶性塩類を除去したのち、40゛C
昇温しでゼラチン75gとフェノキシエタノール0.7
3gを添加し、苛性ソーダと臭化カリによりpH6,5
0,pAg8゜10に調整した。Subsequently, after adding 2.5 g of potassium bromide, 8.3 g of silver nitrate was added.
An aqueous solution containing 3 g was added over 26 minutes so that the flow rate at the end of the addition was twice that at the beginning of the addition. 25 more after this
% ammonia solution 20cc, 50%N HaN0
3 After adding 10 cc and physically aging for 20 minutes,
240 cc of N sulfuric acid was added to neutralize it, and then an aqueous solution of 11,153.34 g of nitric acid and an aqueous solution of potassium bromide were added over 40 minutes by a controlled double jet method while maintaining the potential at p, Ag 8.2. The flow rate at this time was accelerated so that the flow rate at the end of addition was nine times the flow rate at the start of addition. After adding W5, add 2N potassium thiocyanate solution 1
Add 5 cc and then add 25 cc of 1% potassium iodide aqueous solution.
was added over 30 seconds. After this, the temperature was lowered to 35°C, soluble salts were removed by the sedimentation method, and then the temperature was lowered to 40°C.
75g of gelatin and 0.7 phenoxyethanol at elevated temperature
Add 3g and adjust the pH to 6.5 with caustic soda and potassium bromide.
0, pAg was adjusted to 8°10.
温度を56°Cに昇温したのち、下記構造の増感色素を
600■と安定化剤150■を添加した。After raising the temperature to 56° C., 600 μ of a sensitizing dye having the following structure and 150 μ of a stabilizer were added.
10分後にチオ硫酸ナトリウム5水和物2.4■チオシ
アン酸カリ140■、塩化金酸2.1gを乳剤に添加し
、80分後に急冷して固化させて乳剤とした。得られた
乳剤は全粒子の投影面積の総和の98%がアスペクト比
3以上の粒子からなり、アスペクト比2以上すべての粒
子についての平均の投影面積直径は1.051Im、標
準偏差11゜5%、厚みの平均は0.165μmでアス
ペクト比は6.4であった。After 10 minutes, 2.4 parts of sodium thiosulfate pentahydrate, 140 parts of potassium thiocyanate, and 2.1 g of chloroauric acid were added to the emulsion, and after 80 minutes, it was rapidly cooled and solidified to form an emulsion. In the obtained emulsion, 98% of the total projected area of all grains was composed of grains with an aspect ratio of 3 or more, and the average projected area diameter of all grains with an aspect ratio of 2 or more was 1.051 Im, standard deviation 11°5%. The average thickness was 0.165 μm and the aspect ratio was 6.4.
乳剤にハロゲン化銀1モルあたり、下記の薬品を添加し
て塗布液とした。The following chemicals were added to the emulsion per mole of silver halide to prepare a coating solution.
・ボリアクルルアミド
(平均分子! 4,5万)
・ポリマーラテックス
(ポリ (エチルアクリレート
/メタクリル酸)−97/3)
・硬膜剤
1.2−ビス(スルホニルア
23.5g
25.0g
・2,6−ビス(ヒドロキシアミ
ノ)−4−ジエチルアミノ−
1,3,5−)リアジン 80■・ポリアク
リル酸ナトリウム
(平均分子量 4.1万) 4.0g・ポリス
チレンスルホン酸カリウム
(平均分子量 60万) 1.0gクロス
オーバーカ ト の
染料1−1.1−8を特開昭63−197943に記載
の方法でそれぞれボールミル処理した。・Boriaacrylamide (average molecule! 45,000) ・Polymer latex (poly (ethyl acrylate/methacrylic acid) -97/3) ・Hardening agent 1.2-bis (sulfonylua 23.5g 25.0g ・2 ,6-bis(hydroxyamino)-4-diethylamino-1,3,5-)riazine 80 ■ Sodium polyacrylate (average molecular weight 41,000) 4.0 g Potassium polystyrene sulfonate (average molecular weight 600,000) 1.0 g of crossover cut dye 1-1.1-8 was ball milled using the method described in JP-A-63-197943.
・水434dおよびTrlLon X−20OR界面
活性剤(TX−20OR)の6.7%水溶液791jd
とを21のボールミルに入れた。染料20gをこの溶液
に添加した。酸化ジルコニウム(ZrO)のビーズ40
(ld(2m径)を添加し内容物を4日間粉砕した。こ
の後、12.5%ゼラチン160gを添加した。脱泡し
たのち、濾過によりZrOビーズを除去した。得られた
染料分散物を観察したところ、粉砕された染料の粒径は
直径0.05〜1.15μmにかけての広い分布を存し
ていた。・Water 434d and 6.7% aqueous solution of TrlLon X-20OR surfactant (TX-20OR) 791jd
and was placed in a 21 ball mill. 20 g of dye were added to this solution. Zirconium oxide (ZrO) beads 40
(ld (2 m diameter) was added and the contents were ground for 4 days. After this, 160 g of 12.5% gelatin was added. After defoaming, the ZrO beads were removed by filtration. The resulting dye dispersion was When observed, the particle size of the pulverized dye had a wide distribution ranging from 0.05 to 1.15 μm in diameter.
支持体として厚み115amの青色染色した透明PET
支持体を用いた。支持体は親水性コロイド層との密着力
を向上させるため、予め表面をコロナ放電処理したのち
スチレン・ブタジェン ラテツクスからなる第一下塗り
層を設けその上層にゼラチン0.08g/rrfの第二
下塗り層を設けた。Blue-dyed transparent PET with a thickness of 115 am as a support
A support was used. In order to improve the adhesion with the hydrophilic colloid layer, the surface of the support was previously subjected to corona discharge treatment, and then a first undercoat layer made of styrene-butadiene latex was applied, and a second undercoat layer of 0.08 g/rrf of gelatin was applied on top of the first undercoat layer. Layers were provided.
この支持体の両側に下記の塗布量となるように、前記染
料の微細分散物をゼラチン分散溶液として塗布した。こ
うして、クロスオーバーカット層を調製した。A fine dispersion of the above dye was coated as a gelatin dispersion solution on both sides of the support in the coating amount shown below. In this way, a crossover cut layer was prepared.
た の
・ゼラチン f、8g/rrl・染
料1−1 表−1記載の量・染料1
−8 表−1記載の量・ポリスチレ
ンスルホン酸カリウム
(平均分子量 60万) 35■/ポ10■/ボ
・フェノキシエタノール 18ag/rrl
・1,2−ビス(スルホニル
アセトアミド)エタン 100■/ポ次に乳剤層
塗布液を表面保護層塗布液と同時にクロオーバーカット
染料層を塗布した支持体上に両面に塗布した。- Gelatin f, 8g/rrl - Dye 1-1 Amount listed in Table-1 - Dye 1
-8 Quantity listed in Table-1 Potassium polystyrene sulfonate (average molecular weight 600,000) 35■/po10■/bo-phenoxyethanol 18ag/rrl
- 1,2-bis(sulfonylacetamido)ethane 100 μ/p Next, the emulsion layer coating solution was coated on both sides of the support coated with the black overcut dye layer at the same time as the surface protection layer coating solution.
塗布銀量は1.80g/nf(片面あたり)とした。The amount of coated silver was 1.80 g/nf (per side).
表面保護層は各成分が、下記の塗布量となるように調製
し、写真材料1〜6とした(表−1)。The surface protective layer was prepared so that each component was coated in the following amounts, and designated as photographic materials 1 to 6 (Table 1).
l型皿11鬼青産 1査1・ゼラチン
1.15g/ポ・ポリアクリルアミド
(平均分子量 4.5万) 0.25・ポリア
クリル酸ソーダ
(平均分子量 40万) 0.02・p−t
−オクチルフェノキシ
ジグリセリルブチルスルホ
ン化物のナトリウム塩 0102・ポリ(重
合度10)オキシエ
チレンーポリ(重合度3)
オキシグリセリルルーオフ
チルフェノキシエーテル O,(+1・CsF
+tSOJ O,OO3sHq
優 CsH+vSOtN +CH!÷T−十CIt z
+a S Os N ao、001
C3I+ ?
・ CeH+、5OtN +CHtCH*O÷L口+C
Ht CHC11□O+4H0,003
・ポリメチルメタクリレート
(平均粒径 3.5μm) 0.025・ポリ(
メチルメタクリレ−
ト/メタクリレート)
(モル比7:3、平均粒
径2゜5μm) 0.020
互真1皿二評魚
螢光増感紙として、Easts+an Kodak
(株)製のMiniR−Fastを使用した。写真材料
1〜6について距離法によるX線センシトメトリーをお
こない下記の処理(T)〜(V)をおこなった。L-shaped plate 11 Kisei product 1 test 1 gelatin
1.15g/Polyacrylamide (average molecular weight 45,000) 0.25 Sodium polyacrylate (average molecular weight 400,000) 0.02pt
- Sodium salt of octylphenoxy diglyceryl butyl sulfonate 0102・Poly(degree of polymerization 10) Oxyethylene-poly(degree of polymerization 3) Oxyglyceryl-offtyl phenoxy ether O, (+1・CsF
+tSOJ O,OO3sHq Excellent CsH+vSOtN +CH! ÷T-ten CIt z
+a S Os N ao, 001 C3I+?・CeH+, 5OtN +CHtCH*O÷L port +C
Ht CHC11□O+4H0,003 ・Polymethyl methacrylate (average particle size 3.5μm) 0.025・Poly(
Methyl methacrylate/methacrylate) (molar ratio 7:3, average particle size 2゜5μm) 0.020 Easts+an Kodak as a one-plate two-piece fluorescent intensifying screen
MiniR-Fast manufactured by Co., Ltd. was used. Photographic materials 1 to 6 were subjected to X-ray sensitometry using the distance method, and the following treatments (T) to (V) were performed.
感度はFog+1.0の濃度を与えた露光量の逆数の比
であられし、写真材料Iと処理(1)の組合わせを10
0として相対表示をおこなった。Sensitivity is the ratio of the reciprocal of the exposure that gives a density of Fog+1.0, and the combination of photographic material I and processing (1) is 10
Relative display was performed with the value set to 0.
階調は特性曲線曲線(H&D curve)のFog+
0.25の濃度点とFog+2.0の濃度点を結ぶ直線
の傾きで表した。The gradation is Fog+ of the characteristic curve (H&D curve)
It is expressed by the slope of a straight line connecting the density point of 0.25 and the density point of Fog+2.0.
結果を表−1にまとめた。The results are summarized in Table-1.
クロスオーバー の測 l
クロスオーバー光の割合い(%)は米国特許US4,8
03,150と同様に定義される。すなわち、両面に感
光性層を有する感材の片面側のみに、螢光増感紙を密着
させX線を照射する。螢光増感紙の発光は、隣接する感
光性層および染料着色層で吸収されるが、その一部は1
75μmの透明支持体を通過して反対側の乳剤層を感光
させる(この現象をクロスオーバーと呼ぶ)、この時、
螢光増感紙に隣接する感光性層と反対側の感光性層とは
感度差をしようする、この感度差をΔLogEで表した
ときクロスオーバー(%)はクロスオーバー(χ’)=
X 100(ΔLog E)の
真数+1
で定義される。この時の処理は、それぞれの画質や写真
性能を評価する時の方法を適用した。結果を表−1にま
とめた。Measurement of crossover l The percentage of crossover light (%) is as per U.S. Patent No. 4, 8.
03,150. That is, only one side of a photosensitive material having photosensitive layers on both sides is brought into close contact with a fluorescent screen and irradiated with X-rays. The light emitted from the fluorescent screen is absorbed by the adjacent photosensitive layer and dye-colored layer, but some of it is absorbed by the 1
Pass through a 75 μm transparent support to expose the emulsion layer on the opposite side (this phenomenon is called crossover), at this time,
There is a sensitivity difference between the photosensitive layer adjacent to the fluorescent screen and the photosensitive layer on the opposite side. When this sensitivity difference is expressed as ΔLogE, the crossover (%) is crossover (χ') =
It is defined as the antilogous number of X 100 (ΔLog E) +1. At this time, the processing used was the same as the method used to evaluate each image quality and photographic performance. The results are summarized in Table-1.
尚、クロスオーバ光の割合は実験誤差の範囲内で処理内
容によらず一定であった。Note that the ratio of crossover light was constant within the range of experimental error regardless of the processing content.
処ユ方叛」土Y
富士写真フィルム(株)製の自動現像機FRM5000
を用いて下記の現像液(1)で29°C25秒現像した
のち、定着液(1)にて定着し、水洗後乾燥させた。D
ry to Dryの処理時間は87秒であった。Automatic processor FRM5000 manufactured by Fuji Photo Film Co., Ltd.
After developing with the following developer (1) at 29° C. for 25 seconds, it was fixed with fixer (1), washed with water, and then dried. D
The dry to dry processing time was 87 seconds.
央l遣」土と
1−フェニル−3−ピラゾリドン 1.5gヒドロキ
ノン 3085−ニトロイン
ダゾール 0.25g臭化カリウム
3,0g無水亜硫酸ナトリウム
50g水酸化カリウム 3
0g硼酸 Log
グルタルアルデヒド 5g水を加え
て全量を11とする
(pHは10.20に調整した。)
定1丘」土と
チオ硫酸アンモニウム 140g亜硫酸
ナトリウム(無水) 20.0g硼酸
8.0g
エチレンジアミン四酢酸二
ナトリウム・二本塩 0.1g硫酸アルミ
ニウム 15.0g硫酸
2.0g
氷酢酸 22.0g水を加え
て 1.02(pHは4.20
に調整する。)
■の几 ■
下記の現像液(n)で現像したのち定着液(1)にて定
着し、水洗後乾燥させた。Soil and 1-phenyl-3-pyrazolidone 1.5g Hydroquinone 3085-Nitroindazole 0.25g Potassium Bromide
3.0g anhydrous sodium sulfite
50g potassium hydroxide 3
0g Boric acid Log Glutaraldehyde 5g Add water to bring the total volume to 11 (pH adjusted to 10.20) Soil and ammonium thiosulfate 140g Sodium sulfite (anhydrous) 20.0g Boric acid
8.0g Ethylenediaminetetraacetic acid disodium di-salt 0.1g Aluminum sulfate 15.0g Sulfuric acid
Add 2.0g glacial acetic acid 22.0g water to 1.02 (pH is 4.20)
Adjust to. ) After developing with the following developer (n), it was fixed with fixer (1), washed with water, and then dried.
里l鬼ユニL
メトール 2゜亜硫酸ナト
リウム 100gヒドロキノン
5gボラックス・l0H202
g
水を加えて 12(NaO
HにてpH10,5に調整)
自動現像機の駆動モーターの回転数と、現像・定着・水
洗の各々のラック長を調節することで、処理時間を次の
ように設定した。Riki Uni L Metol 2゜Sodium Sulfite 100g Hydroquinone
5g Borax・10H202
g Add water and 12 (NaO
The processing time was set as follows by adjusting the rotation speed of the drive motor of the automatic developing machine and the rack lengths for development, fixing, and washing.
現像 20°c 100秒
定着 20°C60秒
水洗 15℃ 60秒
乾燥を含めてDry to Dryの処理時間は4
分30秒であった。Developing at 20°C for 100 seconds Fixing at 20°C for 60 seconds Washing at 15°C for 60 seconds Dry to Dry processing time is 4.
The time was 30 minutes.
本 Hの八 法 ■
現像液(n)において、NaOHの量を変更し、pH1
1,50とした。処理時間の設定は次の時間配分とした
。Book H-8 Method ■ In the developer (n), change the amount of NaOH and adjust the pH to 1.
It was set at 1,50. The processing time was set according to the following time allocation.
現像 20°C50秒
定着 20℃ 30秒
水洗 15°C25秒
乾燥を含めてDry to Dryの処理時間は2
分45秒。Development: 20°C, 50 seconds fixing, 20°C, 30 seconds washing, 15°C, 25 seconds drying. Dry to dry processing time is 2.
Minutes 45 seconds.
日の 法■
下記の現像液(■)と定着液(1)の組み合わせで処理
をおこなった。Method ■ Processing was carried out using the following combination of developer (■) and fixer (1).
房〕」二ばυ−
メトール 2g亜硫酸ナト
リウム 100gヒドロキノン
15gボラックス・10Hz0
2g水を加えて
1j1!(NaOHにてpH10,1に調整)
現像 35℃ 25秒
定着 30℃ 18秒
水洗 15℃ 12秒
乾燥を含めたDry to Dryの処理時間88
秒。Niba υ- Metol 2g Sodium sulfite 100g Hydroquinone
15g Borax・10Hz0
Add 2g water
1j1! (Adjusted to pH 10.1 with NaOH) Development: 35°C, 25 seconds fixing, 30°C, 18 seconds washing, 15°C, 12 seconds Dry to dry processing time including drying 88
seconds.
の ■
下記の現像液(V)と定着液(1)の組み合わせで処理
をおこなった。(2) Processing was carried out using the following combination of developer (V) and fixer (1).
勇1AL仁!L
メトール 2g亜硫酸ナト
リウム 100gヒドロキノン
10gボラックス・10)(10
2g
5−ニトロインダゾール 0.08gグルタル
アルデヒド 4.3g水を加えて全量を
1ffiとする
(pHは11.0に調整した)
現像 38℃ 18秒
定着 30℃ 11秒
水洗 20℃ 8秒
乾燥を含めたDry to Dryの処理時間60
秒。Yuu 1AL Jin! L Metol 2g Sodium sulfite 100g Hydroquinone
10g borax・10)(10
2g 5-Nitroindazole 0.08g Glutaraldehyde 4.3g Add water to bring the total amount to 1ffi (pH adjusted to 11.0) Development: 38°C, 18 seconds fixing, 30°C, 11 seconds washing, 20°C, 8 seconds including drying Dry to Dry processing time: 60
seconds.
の そのl MTFの
Kodak (株)社製MlniRFast螢光増感紙
を感材の両側に用いてMTF測定用のチャートを38K
VP、100mAのX線照射条件で写真材料1〜6を露
光した。しかるのち処理(1)〜(V)をおこないMT
Fの測定をおこなった。The chart for MTF measurement was set at 38K using MTF MlniRFast fluorescent screens manufactured by Kodak Co., Ltd. on both sides of the photosensitive material.
Photographic materials 1 to 6 were exposed under X-ray irradiation conditions of VP and 100 mA. Afterwards, perform processing (1) to (V) and MT.
F was measured.
MTFについてはT、H,James km集″The
Theory of the Photograph
ic Process (1977Macsillan
社)’592〜61B頁に記載されている。MTFは3
0μmX500μmのアパーチュアで測定し、空間周波
数が3.0サイクル/mの値を用いて評価した。MTF
は両面のまま、光学濃度が0.8の部分にて評価した。For MTF, see T, H, James km collection "The
Theory of the Photography
ic Process (1977Macsillan)
Company) '592-61B. MTF is 3
Measurement was performed using an aperture of 0 μm×500 μm, and evaluation was performed using a value of a spatial frequency of 3.0 cycles/m. MTF
The evaluation was made on both sides and the portion with an optical density of 0.8.
以上の結果を表−1にまとめた。The above results are summarized in Table-1.
の その2. 法
上記の写真材料1〜6と処理(1)〜(V)を用い、M
iniRFast螢光増感紙を両側に使用したシステム
としてファンドーム逼影を実施した。Part 2. Method Using the above photographic materials 1 to 6 and treatments (1) to (V), M
Fan dome imaging was performed as a system using iniRFast fluorescent screens on both sides.
ファンドームの内容はマンモグラフィーにおける微小石
灰化をモデルとして想定し0.21〜0゜8Mのガラス
ピーズを配し背影には乳腺をモデルとした直径0.35
簡のナイロン線によるストラフチャード ノイズを付加
した。The contents of the fan dome are based on the model of microcalcifications in mammography, and glass beads with a diameter of 0.21 to 0.8M are placed on the back, with a diameter of 0.35mm designed to model the mammary glands.
Added strafted noise using simple nylon wire.
こうして、できあがった画像をX線感材研究者5名と放
射線逼影技師5名の計10名によって評価し、ガラスピ
ーズの識別能を比較した。写真材料1〜6と処理(1)
〜(V)の組み合わせで合計30枚の画像ができるが、
これらに各評価者が、識別能の優れていると思う順番に
30ポイント〜1ポイントを与えた(ポイントの多いも
のが優れている)。The images thus created were evaluated by a total of 10 people, including 5 X-ray photosensitive material researchers and 5 radiography technicians, and the discrimination ability of the glass beads was compared. Photographic materials 1-6 and processing (1)
A total of 30 images can be created by combining ~(V),
Each evaluator gave them 30 points to 1 point in the order in which they thought the discrimination ability was better (the one with the most points is better).
10名の評価が終了したのち、各画像に対する10名の
ポイントを合計し得点の多いものから順に番号をつけて
識別能の序列とした。結果を表−1にまとめた。After the evaluation by the 10 people was completed, the 10 people's points for each image were totaled, and numbers were assigned in descending order of the scores to form a ranking of discrimination ability. The results are summarized in Table-1.
写真材料1を処理(1)〜(V)のほうほうで写真性を
評価した時の最高到達濃度とFog濃度の和の1/3濃
度を与えるような露光・現像処理を(+)〜、(■)の
各々についておこなった。Exposure and development processing (+) to give a density of 1/3 of the sum of the maximum density and Fog density when photographic properties of photographic material 1 are evaluated using processing (1) to (V). This was done for each of (■).
ただし現像終了後に定着をせず、酢酸の3%溶液に直ち
に浸漬した。現像を十分停止させたのち、暗室にて水洗
・乾燥した。このあとゼラチン分解酵素アクチナーゼE
(科研製薬(株)製)を用いて、ハロゲン化銀粒子を取
り出しハロゲン化根粒子の現像状態を電子顕微鏡にて観
察した。However, after completion of development, the film was not fixed, but was immediately immersed in a 3% acetic acid solution. After the development was sufficiently stopped, it was washed with water and dried in a dark room. After this, gelatin degrading enzyme actinase E
(manufactured by Kaken Pharmaceutical Co., Ltd.), the silver halide particles were taken out, and the developed state of the halogenated root particles was observed using an electron microscope.
本発明でいうパラレル現像度合を次式で定義する。The degree of parallel development as used in the present invention is defined by the following equation.
本発明の効果の発現のためには、この値は少なくとも1
以上、好ましくは3以上、特に10以上である必要があ
る。In order to exhibit the effects of the present invention, this value should be at least 1
The number needs to be preferably 3 or more, particularly 10 or more.
こうして評価した値を表−2にまとめた。The values evaluated in this way are summarized in Table-2.
尚、写真材料2〜6について同様に評価したところ、誤
差があったが、全体的な傾向としては一敗していた0表
−2にはこの誤差を含めた形で結表−2
表−1の結果より、本発明の方法の識別能が、MTFと
いう物理特性値をとっても、官能評価によっても著しく
優れていることが明らかである。In addition, when we similarly evaluated photographic materials 2 to 6, there were errors, but the overall trend was that Table 0-2, which was a loser, included this error in Table 2 Table- From the results of No. 1, it is clear that the discrimination ability of the method of the present invention is significantly superior both in terms of the physical property value called MTF and in the sensory evaluation.
本発明のシステム21〜24は階調が軟調になって見か
け上のコントラストが低くなっていたが、粒状は極めて
なめらかで、微小ビーズの輪郭は観察しやすかった。官
能評価とMTFの序列が一敗しないのは、階調が高く、
MTFが高いと粒状が荒れて微小切片が見にくい1頃向
が生じ、逆に階調が低いと、粒状はなめらかだが、コン
トライトがつきにくく視覚的に識別しにくい傾向がある
ためで、バランスが重要であることがわかる。In Systems 21 to 24 of the present invention, the gradations were soft and the apparent contrast was low, but the grains were extremely smooth and the outlines of the microbeads were easy to observe. The reason why the ranking of sensory evaluation and MTF is unbeatable is that the gradation is high,
If the MTF is high, the grains will be rough and microsections will be difficult to see, while if the gradation is low, the grains will be smooth but tend to be difficult to distinguish visually due to the lack of contrast. It turns out to be important.
しかしこれらの効果にかかわらず、本発明の識別度は比
較例に対して、はっきりした優位性をもっている。However, in spite of these effects, the degree of discrimination of the present invention is clearly superior to that of the comparative example.
また表−2の結果より、現像活性を高めて現像処理時間
を60秒以下にしたほうが、本発明のパラレル現像度合
は高まり、MTFはより改善された値を示していること
がわかる。Furthermore, from the results in Table 2, it can be seen that when the development activity is increased and the development processing time is set to 60 seconds or less, the parallel development degree of the present invention increases and the MTF shows a more improved value.
比較実施例2
実施例1の着色染料層とを調製したのと同様な方法で支
持体の片側の面のみに下記の染料塗布層を設けた。Comparative Example 2 The following dye coating layer was provided on only one side of the support in the same manner as the colored dye layer of Example 1 was prepared.
・ゼラチン 3.6g/nf・染料
1−1 200■/ポ・染料1−84
00■/イ
・ポリスチレンスルホン酸カリウム
(平均分子量 60万) 25■/イ・ポリメチル
メタクリレート
(平均粒径 3.5μm) 25■/イ・1,2−
ビス(スルホニル
アセトアミド)エタン 200■/イこの染料着
色層とは支持体の反対側に、実施例1の乳剤層と表面保
護層を同時押し出し法で塗布した。・Gelatin 3.6g/nf ・Dye 1-1 200■/po ・Dye 1-84
00■/A Potassium polystyrene sulfonate (average molecular weight 600,000) 25■/A Polymethyl methacrylate (average particle size 3.5μm) 25■/A 1,2-
Bis(sulfonylacetamido)ethane 200 cm/h On the opposite side of the support from the dye-colored layer, the emulsion layer and surface protective layer of Example 1 were coated by coextrusion.
ただし、この時乳剤層の流量だけを、実施例1の2倍と
し、片面での塗布銀量が3.6g/nfとなるようにし
た。However, at this time, only the flow rate of the emulsion layer was twice that of Example 1, so that the amount of silver coated on one side was 3.6 g/nf.
こうして片面感光性写真材料7を得た。In this way, one-sided photosensitive photographic material 7 was obtained.
写真材料7と螢光増感紙Mini RFastを使用
して片面システムとしての画質を評価した。Image quality as a single-sided system was evaluated using Photographic Material 7 and fluorescent intensifying screen Mini RFast.
結果を表−3にまとめた。尚、感度表示は実施例−1と
の相対比較が可能であるように表示した。The results are summarized in Table 3. Incidentally, the sensitivity was displayed so that a relative comparison with Example-1 could be made.
官能評価は個人差があったが、実施例1のシステム1〜
30と較べた時、Q〜[相]位の結果となった。Although there were individual differences in sensory evaluation, system 1 to Example 1
When compared with 30, the result was Q~[phase].
表−3を表−1と較べることにより、本発明のシステム
が従来の片面システムに較べて著しく高感度であり、識
別能においても優れていることがわかる。By comparing Table 3 with Table 1, it can be seen that the system of the present invention has significantly higher sensitivity than the conventional single-sided system, and is also superior in discrimination ability.
本発明は従来のマン上診断用システムに較べて患者の被
爆線量を1/2以下にし、かつ高鮮鋭度な画像を提供し
ている。The present invention reduces the patient's exposure dose to less than half that of conventional manual diagnostic systems and provides highly sharp images.
実施例3
ブルー着色した厚さ175μmのポリエチレンテレフタ
レートベースの両面に片面あたり下記の塗布量の下塗層
を設けたベースを準備した。Example 3 A blue-colored polyethylene terephthalate base having a thickness of 175 μm was provided with an undercoat layer on both sides at the following coating amount per side.
・ゼラチン 180■/イH%C茸
Js
200■/ポ
二のベースに実施例1の乳剤を片面あたりの塗布銀量が
1. 9g/rrfとなるように両面に塗布しこの時、
表面保護層は実施例1と同様の塗布を使用した。硬膜剤
の添加量は、10smol/:)Og−gej!と変更
した。このようにして写真叫8を得た。実施例1と同様
な方法により評価した。・Gelatin 180■/IH%C Mushroom Js 200■/Pony base with the emulsion of Example 1 applied at a coating silver amount of 1. At this time, apply it to both sides so that it is 9g/rrf.
The same coating as in Example 1 was used for the surface protective layer. The amount of hardener added is 10smol/:)Og-gej! It was changed to In this way, photographic image 8 was obtained. Evaluation was performed using the same method as in Example 1.
結果を表−4にまとめた。感度は実施例1.2との相対
比較が可能なように、比学区を表示した。The results are summarized in Table 4. Sensitivity is expressed in percentages to enable relative comparison with Example 1.2.
表−4の結果より、カチオンラテックスを媒染剤として
用いアニオン染料を固定化した場合も、本発明の効果が
存効に発現していることが明らかである。From the results shown in Table 4, it is clear that the effects of the present invention are fully exhibited even when anionic dyes are immobilized using cationic latex as a mordant.
実施例4
クロスオーバーカット の
実施例1と同様に染料■〜l、I−8をボールミル粉砕
処理して直径0.05〜1.15μmの微細染料分散物
を得た。Example 4 Crossover Cut Dyes 1 to 1 and I-8 were ball milled in the same manner as in Example 1 to obtain a fine dye dispersion having a diameter of 0.05 to 1.15 μm.
この各々の染料分散物を遠心分離機にかけ粗粒子を沈澱
させたのち、その上済み液を採取した。Each dye dispersion was centrifuged to precipitate coarse particles, and the supernatant liquid was collected.
得られた染料は粒径が0.05〜0.15μmにわたる
超微細染料分散物であった。The resulting dye was an ultrafine dye dispersion with a particle size ranging from 0.05 to 0.15 μm.
支持体として厚み175μmの青色染色した透明PET
支持体を準備した。支持体の親水性コロイド層との密着
力を向上させるため、予め表面をコロナ放電処理したの
ちスチレン・ブタジェンラテックスからなる第一下塗層
を、両面に設けた。Transparent PET dyed blue with a thickness of 175 μm as a support
A support was prepared. In order to improve the adhesion to the hydrophilic colloid layer of the support, the surface was previously subjected to corona discharge treatment, and then a first undercoat layer made of styrene-butadiene latex was provided on both sides.
この上に、下記の組成からなる第2のゼラチン下塗層を
、両面に塗布した。On top of this, a second gelatin undercoat layer having the following composition was coated on both sides.
あた の
・ゼラチン 0.25g/ポ・染料■
の超微細分散物 80■/rdの染料Hの超微
細分散物 160■/rrf8を4ツ切サイズ(
24X30C11)に裁断し、各々の感材の連続処理を
おこなった。Atano・Gelatin 0.25g/Po・Dye■
Ultrafine dispersion of 80■/rd Ultrafine dispersion of dye H 160■/rrf8 cut into 4 pieces (
Each photosensitive material was cut into pieces of 24×30C11) and subjected to continuous processing.
結果を表−5にまとめた。The results are summarized in Table-5.
LoI1g/rrl
実施例1とまったく同様にして乳剤層と表面保護層を上
述の下塗層を塗布済の支持体に塗布した。LoI 1 g/rrl In exactly the same manner as in Example 1, an emulsion layer and a surface protective layer were coated on a support coated with the above-mentioned undercoat layer.
こうして写真材料9を得た。Photographic material 9 was thus obtained.
■の と の。■'s and's.
実施例1の処理(V)をおこなった、この時の乾燥条件
は乾燥風温度は50℃とし、乾燥ゾーンでの感材の滞在
時間は10秒であった。Process (V) of Example 1 was carried out under drying conditions such that the drying air temperature was 50° C. and the residence time of the photosensitive material in the drying zone was 10 seconds.
実施例1の写真材料5と、本実施例の写真材料表−5の
結果より、超微細染料分散物を下塗層に塗布し、クロス
オーバーカット着色層とする本発明の方法は、Dry
to Dry60秒という超高画質でありながら超
迅速処理であるような本実施例において、鮮鋭度、感度
、連続処理における乾燥性のいずれの点をとっても優れ
ており、本発明の中でもっとも好ましい態様であること
がわかる。From the results of Photographic Material 5 of Example 1 and Photographic Material Table 5 of this Example, the method of the present invention in which an ultrafine dye dispersion is applied to an undercoat layer to form a crossover cut colored layer is
In this embodiment, which has an ultra-high image quality of 60 seconds to dry and ultra-quick processing, it is excellent in terms of sharpness, sensitivity, and drying performance in continuous processing, and is the most preferred embodiment of the present invention. It can be seen that it is.
実施例5
1M■皿袈
水1!中に臭化カリ5g1ゼラチン20g1チオエーテ
ルHO(CHI)オS (CHz)xs (CHり10
Hの5%水溶液2.5ccを添加し65°Cに保った
容器中へ、撹拌しながら硝酸銀8.33gの水溶液と臭
化カリ5.94g、沃化カリ0.726gを含む水溶液
とをダブルジェット法により45秒間で添加したヶ続い
て臭化カリ2.7gを添加したのち硝酸m8.33gを
含む水溶液を14分間かけて添加した。このあと25%
のアンモニア水溶液20cc、50%のNHa NOs
10ccを添加して20分間物理熟成したのちIN
の硫酸240ccを添加して中和した。Example 5 1M ■Sarakesui 1! Potassium bromide 5g 1 gelatin 20g 1 thioether HO (CHI) (CHz)xs (CH 10
A solution containing 8.33 g of silver nitrate, 5.94 g of potassium bromide, and 0.726 g of potassium iodide was added to a container containing 2.5 cc of a 5% aqueous solution of H and kept at 65°C while stirring. The mixture was added by a jet method over a period of 45 seconds, followed by the addition of 2.7 g of potassium bromide, and then an aqueous solution containing 8.33 g of nitric acid over a period of 14 minutes. 25% after this
20 cc of ammonia aqueous solution, 50% NHa NOs
After adding 10cc and physically aging for 20 minutes, IN
240 cc of sulfuric acid was added to neutralize.
引き続いて硝酸銀153.34gの水溶液と、臭化カリ
と沃化カリの混合水溶液を、電位をp/Ig8.05に
保ちながらコントロールダブルジェット法で45分間で
添加した。この時の流量は添加終了時の流速が添加開始
時の8倍となるように加速した。このコントロールダブ
ルジェットにおいて添加された沃化カリの量はKlとし
て12gであった。Subsequently, an aqueous solution of 153.34 g of silver nitrate and a mixed aqueous solution of potassium bromide and potassium iodide were added over 45 minutes by a controlled double jet method while maintaining the potential at p/Ig 8.05. The flow rate at this time was accelerated so that the flow rate at the end of addition was eight times that at the start of addition. The amount of potassium iodide added in this control double jet was 12 g as Kl.
添加終了後2Nのチオシアン酸カリウム溶液30ccを
添加した。このあと35°Cに降温し、沈降法により可
溶性塩類を除去したのち、40℃に昇温してゼラチン7
0gとフェノキシエタノール0.7gを添加し、Na
OHと臭化カリによりpH6,85、PAg8.Oに調
整した。温度を65°Cに昇温したのち、実施例1の増
感色素65omgとハロゲン化銀安定化剤300■を添
加した。After the addition was complete, 30 cc of 2N potassium thiocyanate solution was added. After that, the temperature was lowered to 35°C, soluble salts were removed by the sedimentation method, and then the temperature was raised to 40°C to remove gelatin.
0g and phenoxyethanol 0.7g, Na
pH 6.85, PAg 8.0 by OH and potassium bromide. Adjusted to O. After raising the temperature to 65°C, 65 omg of the sensitizing dye of Example 1 and 300 μg of silver halide stabilizer were added.
10分後にチオ硫酸ナトリウム5水和物3■、チオシア
ン酸カリ140mg塩化金酸2.5■を添加し10分後
に冷却して乳剤とした。After 10 minutes, 3 parts of sodium thiosulfate pentahydrate, 140 mg of potassium thiocyanate, and 2.5 parts of chloroauric acid were added, and after 10 minutes, the mixture was cooled to form an emulsion.
得られた乳剤は平均投影面積直径1.16μm、標準偏
差16.8%、厚みの平均は0.171μmでアスペク
ト比は6.8であった。The resulting emulsion had an average projected area diameter of 1.16 μm, a standard deviation of 16.8%, an average thickness of 0.171 μm, and an aspect ratio of 6.8.
以後、実施例1と同様に薬品を添加して乳剤塗布液を完
成した。Thereafter, chemicals were added in the same manner as in Example 1 to complete an emulsion coating solution.
亙真林料工五星l
実施例4で準備したのと同様にして超微細染料分散物を
下塗層に塗布した支持体を準備した。A support coated with an ultrafine dye dispersion on the undercoat layer was prepared in the same manner as prepared in Example 4.
この支持体の両面に、前述の乳剤塗布液と実施例1と同
じ表面保護層とを塗布した。The above-mentioned emulsion coating solution and the same surface protective layer as in Example 1 were coated on both sides of this support.
塗布銀量は片面あたり2.0g/nfとなるように塗布
した。The amount of silver coated was 2.0 g/nf per side.
こうして写真材料10を得た。Photographic material 10 was thus obtained.
血皿脛l 実施例−1の処理(I)にて各種の性能を評価した。blood dish shin Various performances were evaluated in the treatment (I) of Example-1.
結果を表−6にまとめた。The results are summarized in Table-6.
表−6の結果より、システムNα38も本発明の高感度
で超高鮮鋭度の特徴をそなえていることがわかる。From the results in Table 6, it can be seen that the system Nα38 also has the features of the present invention of high sensitivity and ultra-high sharpness.
ハロゲン化銀組成を写真材料10のように高めてやると
(AgBr I :Ag I含17.67モル%)処理
H)のような従来パラレル型現像でなかった処理剤でも
、本発明のパラレル型(parallelfashio
n )を実現できることがわかる。When the silver halide composition is increased as in Photographic Material 10 (AgBr I: Ag I content: 17.67 mol %), even processing agents that were not conventionally used for parallel type development, such as processing H), can be used with the parallel type development of the present invention. (parallelfashio
It can be seen that n) can be realized.
特許出願人 富士写真フィルム株式会社手続補正書 4、 補正の対象 明細書の「発明の詳細な説明」 の欄 平成1 7月 日Patent applicant: Fuji Photo Film Co., Ltd. Procedural amendment 4. Subject of correction “Detailed description of the invention” in the specification column Heisei 1 July Day
Claims (2)
光性ハロゲン化銀乳剤層を有する医療用写真感光材料を
現像処理するX線画像形成方法において、該写真感光材
料のクロスオーバー光が12%以下でありハロゲン化銀
乳剤の現像進行状態がパラレル型現像であることを特徴
とするX線画像形成方法。(1) In an X-ray image forming method for developing a medical photographic material having at least one photosensitive silver halide emulsion layer on each side of a transparent support, the cross-over light of the photographic material is 12% or less. An X-ray image forming method characterized in that the development progress state of the silver halide emulsion is parallel development.
許請求の範囲第1項に記載のX線画像形成方法。(2) The X-ray image forming method according to claim 1, wherein the developing time is 60 seconds or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8736689A JPH02264944A (en) | 1989-04-06 | 1989-04-06 | X-ray image forming method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8736689A JPH02264944A (en) | 1989-04-06 | 1989-04-06 | X-ray image forming method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02264944A true JPH02264944A (en) | 1990-10-29 |
Family
ID=13912897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8736689A Pending JPH02264944A (en) | 1989-04-06 | 1989-04-06 | X-ray image forming method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02264944A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1750173A1 (en) | 2005-08-04 | 2007-02-07 | Fuji Photo Film Co., Ltd. | Silver halide photosensitive material and packaged body containing the same |
-
1989
- 1989-04-06 JP JP8736689A patent/JPH02264944A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1750173A1 (en) | 2005-08-04 | 2007-02-07 | Fuji Photo Film Co., Ltd. | Silver halide photosensitive material and packaged body containing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1183381A (en) | Silver halide photographic light-sensitive material having tabular and non-tabular silver halide emulsion layers and a surface protecting layer | |
JPH0782207B2 (en) | Silver halide photographic material for X-ray | |
US5449599A (en) | Silver halide light-sensitive photographic material with enhanced image quality for rapid processing applications in mammography | |
JPH0627561A (en) | Manufacture of flat silver halide particle | |
US5015562A (en) | Light-sensitive silver halide element containing modant, dye and sonic polymer | |
JP2876081B2 (en) | Silver halide photographic material | |
JPH01166031A (en) | Silver halide photographic material | |
JPH0820693B2 (en) | Silver halide photographic material | |
JPH0640200B2 (en) | Silver halide photographic light-sensitive material for radiation | |
JPH02264944A (en) | X-ray image forming method | |
US5674675A (en) | Silver halide photographic material | |
US5077184A (en) | Silver halide photographic material containing color reversible dye layer | |
JPH01179145A (en) | Silver halide photographic sensitive material | |
US5230993A (en) | Silver halide photographic element | |
JPH0311454B2 (en) | ||
JP2639431B2 (en) | Silver halide photographic material | |
JPS63249839A (en) | Silver halide photographic sensitive material | |
EP0610608B1 (en) | Silver halide light-sensitive photographic material for use as a laser recorded medical hardcopy material and method of processing | |
JP2995641B2 (en) | Processing method of silver halide photographic material | |
JP2906288B2 (en) | Method for producing photographic silver halide emulsion | |
JPH04307539A (en) | Silver halide photographic sensitive material | |
JP2789368B2 (en) | X-ray silver halide photographic material | |
JPH02266352A (en) | Silver halide photographic sensitive material for x-ray photography | |
JPH03248150A (en) | X-ray image forming method | |
JPH0823670B2 (en) | Silver halide photographic material |